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ABSTRACT
The purpose of this dissertation project is to add to the growing literature about
the multi-faceted aspects of colorectal cancer (CRC) prevention and related disparities.
We focused on the spatial distribution of facilities performing screening services to
identify areas that underutilize colonoscopy screening. Next, we examined how the food
and physical activity environment affects precursors of CRC by considering plausible
pathways. Finally, we explored if access to health insurance reduced the racial disparity
of receiving a timely surveillance colonoscopy after a CRC diagnosis.
We utilized the SC Ambulatory Surgery Discharge Database, an all-payer,
population-based outpatient dataset with colonoscopy records from 2000 – 2014. To
identify individuals with a personal history of CRC, we used the SC Central Cancer
Registry. We used the Colorectal Cancer Prevention Network screening cohort of lowincome, uninsured adults in SC to study colorectal polyps. We paired these unique
datasets with innovative analysis methods like two-stage Bayesian hierarchical logistic
regression, causal mediation analysis, and loglinear regression.
We were able to create catchment areas (CAs) for all facilities in SC performing
screening colonoscopies and found that only a small proportion of ZIP codes were not
included in any CA. Aspects of the food and physical activity environment had a direct,
protective effect on having high-risk colorectal polyps. Finally, we found that over time,
increased access to health insurance helped to diminish the racial disparity in receiving a
timely surveillance colonoscopy.
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Overall, this dissertation was able to address gaps in the literature, particularly
providing risk and prevalence estimates for the state of South Carolina (SC). This work
lays the foundation for addressing screening and surveillance capacity in SC and
understanding the individual role within unhealthy environments.

vi

TABLE OF CONTENTS
Dedication .......................................................................................................................... iii
Acknowledgements ............................................................................................................ iv
Abstract ................................................................................................................................v
List of Tables ................................................................................................................... viii
List of Figures .................................................................................................................... ix
List of Abbreviations ...........................................................................................................x
Chapter 1: Introduction ........................................................................................................1
Chapter 2: Literature Review ...............................................................................................7
Chapter 3: Methods ............................................................................................................27
Chapter 4: Catchment area analysis for colonoscopy centers in South Carolina ..............34
Chapter 5: The obesogenic environment and colorectal polyps: A mediation analysis
approach ............................................................................................................................49
Chapter 6: Increased insurance access and surveillance of colorectal cancer ...................67
Chapter 7: Summary ..........................................................................................................81
References ..........................................................................................................................84
Appendix A: Codes to identify colonoscopy ...................................................................103
Appendix B: Prevalence estimates over time ..................................................................104

vii

LIST OF TABLES
Table 4.1 Characteristics of patients seeking a screening colonoscopy in South
Carolina, 2010 – 2014 ........................................................................................................46
Table 4.2 Odds ratios of patient demographics for a sample facility in South Carolina ...47
Table 5.1 Characteristics of participants and polyp detection in the CCPN Program,
January 2014 – August 2018..............................................................................................64
Table 5.2 Decomposition of effects of the obesogenic environment on having a polyp ...66
Table 6.1 Baseline characteristics of adults diagnosed with CRC from 2001 – 2013 .......78
Table 6.2 Adjusted prevalence ratios (95% CI) stratified by diagnosis year and age group
for adherence to the one-year surveillance colonoscopy. ..................................................79

viii

LIST OF FIGURES
Figure 3.1 Directed acyclic graph illustrating the relationship between the obesogenic
environment and polyps through obesity ...........................................................................33
Figure 4.1 Map of the 98 colonoscopy facilities and their catchment areas in South
Carolina, 2010 – 2014 ........................................................................................................48
Figure 6.1 Formation of the study population of adults diagnosed with CRC. .................80
Figure 6.2 Age-adjusted prevalence of one-year surveillance colonoscopy in South
Carolina for male and female CRC survivors from 2002 – 2013 ......................................80

ix

LIST OF ABBREVIATIONS
ADR ................................................................................................ Adenoma detection rate
ASD....................................................................................... Ambulatory Surgery Database
CA .................................................................................................................Catchment area
CIMP ............................................................................... CpG island methylator phenotype
CCPN ...................................................................... Colorectal Cancer Prevention Network
CRC........................................................................................................... Colorectal cancer
CRS ......................................................................................................... Colorectal surgeon
FAP .................................................................................. Familial Adenomatous Polyposis
GE ............................................................................................................ Gastroenterologist
GS ............................................................................................................... General surgeon
LS ................................................................................................................Lynch syndrome
MSI ................................................................................................ Microsatellite instability
OEI .......................................................................................Obesogenic environment index
PDR ........................................................................................................Polyp detection rate
PCCRC........................................................................... Postcolonoscopy colorectal cancer
PCP ..................................................................................................Primary Care Physician
SC.................................................................................................................. South Carolina
SCCCR................................................................... South Carolina Central Cancer Registry
U.S. .................................................................................................................. United States

x

CHAPTER 1
INTRODUCTION
Colorectal cancer (CRC) is cancer of the large intestine (colon) or rectum; it is
considered a disease of the developed world.1 Overall, men and women in the United
States have approximately a 5% lifetime risk of developing colorectal cancer2, and it is
the third most common cancer, affecting mostly adults over 50 years old. For 2017, the
American Cancer Society estimated that 67,800 deaths were attributable to CRC.3 More
specifically, CRC was estimated to be the second leading cause of cancer death in the
United States (U.S.) and South Carolina (SC) for the same year.
CRC is largely preventable through primary and secondary prevention methods
and reduce the risk of CRC through maintaining a healthy lifestyle, which include a
healthy diet (5-8%), physical activity (16%), not smoking (12%), and regular screenings
(63%).1,4–6 Screening has become more affordable over the last two decades due to
Medicare’s determination to cover colonoscopy for average-risk individuals in 2001 and
the more recent Affordable Care Act making screening available to nearly all insured
average-risk individuals with no out-of-pocket costs, yet only 67.6% of eligible adults
have received any type of screening.7 Research has shown that the barriers to CRC
screening include lack of awareness, affordability, distance to a screening facility, lack of
symptoms, and views of cancer fatality.8–10
CRC survival is relatively high compared to other cancers, but dependent on
numerous factors. The five-year survival is 65% overall, and ranges from 14% to 90% for
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distant and localized stage, respectively.3 Research on survival and recurrence after a
CRC diagnosis is limited, and somewhat inconclusive.11 However, it is suggested that
primary prevention methods like reduced processed food consumption and physical
activity reduce recurrence after a CRC diagnosis as well.12,13 In addition, consistent
surveillance is recommended to prevent CRC recurrence. Colonoscopy is primarily
recommended, however the method and intervals of testing vary by family history, polyp
size, age, and location of the tumor.14,15 Factors preventing prolonged survival include
financial burden16,17 and lack of social support18,19.

1.1 Statement of the Problem
Over the last two decades, there has been an overall decrease in CRC mortality in
the U.S. population.3 This may be due to increased CRC screening and improved
treatment. While any reduction in CRC morbidity or mortality is considered a victory,
certain populations are still at a disadvantage compared to others. There are consistent
disparities in CRC outcomes between Black and White Americans,4,20 lower and upper
SES,21 and rural and urban Americans22,23. Compared to Whites, African Americans are
more likely to be diagnosed with and die from CRC.3,24 This could be due to less
understanding about screening and lower screening rates, even when there is a known
family history of the disease.24,25 African Americans are also more likely to be diagnosed
at later stages, which is directly related to survival.25–27 In addition, individuals of lower
socioeconomic status have a higher risk of CRC incidence and mortality.25,28 This
disparity is not always mitigated by insurance.29–31 Finally, compared to those residing in
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urban areas, rural residents are less likely to receive screening, have higher CRC
incidence rates, and later stages at diagnosis.22,23,32,33
Progress in reducing colorectal cancer death rates and disparities can be
accelerated by improving access to screening/surveillance, and providing high-quality,
timely treatment in all populations.20 Particularly in South Carolina, there is large
intersectionality of African American living in rural areas compared to the national
distribution34, and due to the lack of Medicaid expansion, high rate of no insurance, and
large minority representation, these disparities may be compounded. Similar disparities
are noted for prevention opportunities like access to affordable healthy food outlets.35,36
Across the U.S., predominately rural, low income, or ethnic minority communities have
less access to quality food and supermarkets,37 which is directly related to chronic
diseases like CRC.

1.2 Purpose & Aims
The purpose of this project is to investigate disparities in travel patterns of CRC
screening (Paper 1), obesogenic environmental effects on CRC screening outcomes
(Paper 2), and adherence to post CRC diagnosis surveillance (Paper 3) in SC.
Aim I: To determine the catchment areas of facilities performing screening
colonoscopies and the associated travel patterns of their patients in South Carolina.
The purpose of this project is to illustrate and describe the catchment areas (CA; i.e.
service area) of facilities in SC providing screening colonoscopies from 2010 – 2014.
Catchment area analyses help describe the types of people that are more likely utilize a
service in specific locations. Using data from the population-based SC Outpatient
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Ambulatory Discharge database, we will construct CAs and examine travel patterns of
age-eligible adults seeking a screening colonoscopy. The following research questions
will be answered within this aim:
1. What is the greatest distance that patients are willing to travel? How does it differ
by patient rurality?
2. What are the characteristics of patients inside and outside of the catchment areas?
Aim II: To determine the relationship between the obesogenic environment and the
presence of colorectal polyps among patients screened for CRC. Poor access to
recreational opportunities and healthy food outlets can be barriers to living a healthy
lifestyle, and are more pervasive in low-income and rural neighborhoods.38,39 Although
the environment is a social determinant of health, its role in CRC has not been clearly
established, as studies have produced mixed results.40–42 Using a low-income, uninsured
screening cohort from the Colorectal Cancer Prevention Network sponsored by the
University of South Carolina, we propose to:
1. Examine the pathways between the obesogenic environment and the presence of
CRC polyps.
2. To explore whether the association of the obesogenic environment on the
presence CRC polyp(s) differs by polyp type (any and high-risk).
Hypotheses:
1. The pathway between the obesogenic environment and having a polyp is mostly
mediated through obesity.
2. The direct pathway (not through individual-level obesity) has a stronger effect on
high-risk polyps than the general class of polyps.
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Aim III: To determine if racial disparities in CRC surveillance adherence diminish
over time with increased access to health care as measured by insurance
coverage. CRC survivors are at an increased risk of CRC recurrence. After a cancer
diagnosis and treatment, there are several steps that a survivor can take to protect their
quality of life; surveillance is a key step. A surveillance colonoscopy is recommended
one year after a colorectal cancer (CRC) diagnosis and treatment to detect early signs of
recurrent cancer.43 Adherence to this recommendation varies widely, and uptake is
suboptimal among minority populations.44 Using data from the SC Outpatient
Ambulatory database linked to the SC Central Cancer Registry, we propose to:
1. Describe surveillance uptake overtime in SC among patients diagnosed with
CRC.
2. To examine racial disparities in adherence to surveillance by age group over time.
Hypothesis: The disparity between older (≥ 65) African American and White patients is
significantly reduced for colorectal cancer surveillance adherence due to increased access
to health care through insurance.

1.3 Significance & Rationale
In 2014, the National Colorectal Cancer Roundtable announced an initiative to
screen 80% of age-eligible adults by 2018. In the same year, approximately 68% of SC
adults aged 50 and over were up-to-date on any CRC screening.45 Population screening is
imperative in reducing the incidence and mortality of CRC, therefore it is important to
establish and verify beneficial agents and potential barriers to receiving CRC-related
services. In SC, the clusters of centers performing colonoscopy, particularly in urban
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areas, may create pockets of poor accessibility to colonoscopy services where people
must travel a great distance to be screened for CRC. Therefore, it is of great interest to
visualize and understand the catchment areas of these centers, and the corresponding
population that they reach and attract. This analysis (for Aim 1) has not been done for
colonoscopy centers in SC and has the potential to inform the colonoscopy centers of the
range of their service.
It is widely known that living in a healthier environment, or an environment with
health-promoting opportunities, is associated with better health outcomes. However, the
relationship between the obesogenic environment and CRC has not been well established.
Aim 2 seeks to determine if areas with less healthy options influence colorectal outcomes
outside of the known pathway through obesity. A significant finding would draw
attention to neighborhoods that appear “unhealthy” to determine a true cause of the
outcome.
Finally, adherence to surveillance after a CRC diagnosis is not as well studied as
CRC screening. Aim 3 will establish the prevalence of surveillance uptake in SC over
time and across racial/ethnic and age groups, which currently does not exist. This is an
important step in recognizing how disparities change over time and potential intervention
targets for CRC survivors at the highest risk of surveillance non-adherence.
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CHAPTER 2
LITERATURE REVIEW
2.1 Anatomy4,46
The colon, or the large intestine, removes water, breaks down and extracts
remaining nutrients in the digestive process. Using the muscles that line the colon wall,
the residual contents, called stool, are pushed to the rectum, then finally out of the body
through the anus. The colon is comprised of four sections: the ascending, transverse,
descending, and sigmoid colon. The ascending colon begins at the cecum, which
connects the colon to the small intestine, and runs up the right side of the abdomen. The
transverse colon runs above the abdomen and is the connection between the ascending
and descending colon. The descending colon runs down the left side of the abdomen,
connects to the sigmoid colon, which is joined to the rectum. The ascending and
transverse colon are also referred to as the proximal colon, and the descending and
sigmoid are referred to as the distal colon. Together, the colon and rectum are
approximately six feet long.
The colon is a tubular organ with multiple layers. The innermost layer of the
colon and rectum is the mucosa. The mucosa is comprised of the epithelium, connective
tissue or the lumen, and thin strips of muscle. The submucosa is a layer of connective
tissue containing mucous glands, blood vessels, lymphatic vessels, and nerves
immediately beneath the mucosa. The muscularis propia is a thick layer of muscle that
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lies just below the submucosa. Finally, the serosa is the outermost layer and the only
layer not found on the rectum.

2.1.1 Polyps
In certain situations, the mucosal layer can become hyperproliferative and form a
benign growth called a polyp. Polyps can be complex, vary in size, and location of the
colon and rectum. Inflammatory, hyperplastic and adenomas (i.e. adenomatous polyps)
are the most common. Inflammatory polyps are typically found in the colon of those with
inflammatory disease like Crohn’s disease or ulcerative colitis.47 Inflammatory and
hyperplastic polyps typically will not develop into cancer, and they both can be removed
during a colonoscopy.47,48

2.1.2 Adenomas
Adenomas arise from the glandular cells found on the mucosal surface; the
purpose of these cells is to produce the mucous that lubricates the colon and rectum. CRC
develops through one of three pathways: 1) the adenoma-carcinoma pathway (most
common for sporadic CRC), 2) the CpG island methylator phenotype (CIMP), high
microsatellite instability, and 3) the microsatellite instability through mismatch repair
pathway.49,50 Adenomatous polyps are precursors to CRC and account for 96% of all
CRCs.7 These polyps arise through the first pathway and can be classified into tubular,
villous, tubulovillous (a mix), or serrated. Tubular adenomas are protruding, spherical,
and pedunculated (i.e. elongated) and account for about 80% of adenomas found in the
colon and have a less than a 5% chance of progressing to cancer.51 Tubulovillous
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adenomas account for 10 – 15% of adenomas and have an elevated risk of malignancy of
20 – 25%.51 Villous adenomas are typically sessile with a hairy-like surface, account
about 5 – 10% of adenomas, and have between 30 – 45% chance of progressing to
cancer.51 Serrated adenomas have a sawtooth appearance and are responsible for
approximately 30% of colorectal cancers.52
Serrated adenomas/polyps arise from the CIMP pathway and can be classified as
hyperplastic, sessile, and traditional. This pathway is particularly important because
individuals with serrated polyps have a higher risk of CRC compared to individuals with
other advanced adenomas.53 Traditional serrated adenomas are smaller in size and rare,
and sessile serrated polyps are typically located in the proximal colon and tend to be
missed during endoscopic procedures, which leads to interval cancer.52,54 Because of the
malignancy of serrated polyps, surveillance after a polypectomy are more frequent than
the standard 10 year interval, ranging from 3 – 5 years.50,55
The Microsatellite instability (MSI) pathway is caused by mutations in the
mismatch repair (MMR) gene. Microsatellites are short repeats of DNA sequences.
Instability occurs when the number of repeats is different from the number of inherited
DNA repeats.56 Previous research has estimated that MSI accounted for 13% of sporadic
CRC.57 MSI tumors are mostly found on the right side and individuals diagnosed with a
MSI-positive tumor have better prognosis and overall survival compared to other rightsided tumors.58,59
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2.2 Biological Causes of Colorectal Cancer
CRC is a consequence of genetic and epigenetic mutations that transform normal
tissue into adenocarcinoma.60 Like most cancers, CRC is a multifactorial disease, and
results from the inability to control cell replication and differentiation.61 For example,
inactivation of tumor suppressor genes due to DNA mutation can trigger tumorigenesis.
Tumorigenesis, or the initiation of CRC, develops overtime from precancerous polyps. In
the most common pathway, these polyps advance in size from small to larger
adenoma(s), then finally to cancer.62 While large adenomas are associated with higher
malignancy, most adenomas found in the colon or rectum are small, having a diameter
less than one cm.63,64
Genetics play a role, with increased predisposition to CRC related to familial
diseases, like Lynch Syndrome or Familial Adenomatous Polyposis. Of note, these high
risk individuals only account for 5 – 10% of all diagnosed cases.65 Another known
pathway to CRC is through aberrant DNA methylation. DNA methylation is the process
of activating or silencing cell activity. Previous research has shown that aberrant
hypermethylation in specific regions has the potential to silence tumor suppressor genes;
the downstream effect is the same as mutation-induced inactivation of tumor suppressor
genes as previously discussed.60 Increasing evidence shows a connection between
lifestyle factors and epigenetic modification. Raskov et al. noted that mucosal cells
quickly adapt to carcinogens and diet changes which result in epigenetic changes, and can
result in tumor formation; these changes can be amplified if genetic predispositions
already exist.66
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Many of the molecular-focused studies consistently found smoking to increase the
risk of CRC through the serrated pathway, with the highest risk (Hazard Ratio ≈ 2)
associated with MSI.62 Smoking cessation was found to have a protective effect on the
DNA methylation pathway where at least 10 years of cessation was associated with a
50% lower risk of CIMP-high CRC.67 The effect of dietary patterns also differed by
microsatellite stable (MSS) tumors where an increased consumption of red meat, total
and saturated fats, and cholesterol were associated with increased odds of CRC.68 Some
epidemiologic studies have also found obesity to be positively associated with CRC for
MSS tumors.69,70

2.3 Disease Progression
The progression from onset to colorectal cancer symptoms can take up to 20 years
for the average risk population, or as little as three years in patients with familial
predisposition for familial diseases.2,60 CRC typically begins as a small adenomatous
polyp and the probability of cancer increases as the adenoma grows.4 Approximately 30 –
50% of individuals will develop at least one adenoma, but less than 10% progress to
cancer.71 Adenocarcinoma, developed from abnormal proliferation of the glandular cells,
is the most common form of CRC (96% of cases).7 The stage of CRC indicates the
severity, or spread of cancer. CRC begins on the inner lining of the colon or rectum (in
situ), expands to the colon or rectum wall (local), into the lymph and blood vessels
(regional), then into other organs (distant).4 Approximately 38% and 43% of patients are
diagnosed with colon and rectum cancer at the localized stage, respectively, where the
survival rate is highest.7
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There are usually no signs or symptoms at the onset and early stages of CRC. As
the cancer develops, individuals may experience bloody stool, bleeding from the rectum,
a change in the color or shape of stool, discomfort in the abdomen area, unintentional
weight loss, vomiting, constipation or diarrhea, or a decreased appetite.72 Although there
are a lack of symptoms in the progression of CRC, it can be caught early or prevented
with various screening methods.

2.4 Observational & Randomized Control Trial findings
CRC is a multifactorial disease that is influenced by both modifiable and nonmodifiable risk factors. There are two hereditary patterns related to CRC, those that are
associated with colon polyps (polyposis) and those that are not (non-polyposis).
Individuals with a family history have the greatest lifetime risk of developing CRC.
Those with one first-degree relative diagnosed CRC have two times the risk, and those
with more than one relative have four times the risk of developing CRC.73 Epidemiologic
studies also show an association between incidence of sporadic CRC and lifestyle
behaviors like heavy red meat consumption, smoking, large body weight, and lack of
physical activity.7,74,75

2.4.1 Genetics
Familial Adenomatous Polyposis (FAP) is a genetic disorder that has both
autosomal dominant and autosomal recessive forms, and has an incidence of 1 per 8,000
– 10,000, which only accounts for <1% of all CRC cases.1,76 An individual with FAP can
develop hundreds to thousands of colonic polyps that increase in frequency with age;
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these polyps can progress to cancer if not removed. In the milder (recessive) form of
FAP, an individual can develop less than 100 polyps over a lifetime. Individuals with
FAP or attenuated FAP have almost a 100% lifetime risk of developing CRC, which is
significantly greater than the sporadic forms. The average age of CRC onset is 39 for
FAP and 55 for attenuated (delayed) FAP, compared to 69 for the average risk
population. The cause of FAP and its attenuated form is a mutation of the adenomatous
polyposis coli (APC) gene, a tumor suppressor gene that control normal cell growth and
function.77 The cause of autosomal recessive FAP is a mutation in the MUTYH gene,
which controls DNA correction during the replication process before cell division.
Lynch syndrome (LS), or hereditary nonpolyposis colorectal cancer, is an
autosomal dominant that accounts for 3% of the new cases of CRC.78 LS manifests
through the MSI pathway by variations in the MMR genes: MLH1, MLH2, MLH6,
PMS2, and EPCAM.57,79 Similar to FAP, these genes are involved in repairing errors
during DNA replication. The continuation of more cells dividing and replicating with
errors leads to uncontrolled cell growth, and possibly malignant tumors. LS does not only
lead to CRC, it can lead to cancer of related and distant organs like the digestive organs,
the upper urinary tract, brain, and skin.78

2.4.2 Polyp Location
The location of a colon polyp or adenomatous tissue has implications for the
severity and survival of CRC. Individuals with right-sided cancer are more likely to
experience interval cancer (i.e. cancer between screenings),80 and have a higher risk of
mortality.58,81 The increase in mortality is related to right-sided cancers being diagnosed
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at later stages and in older adults, which leads to poorer survival compared to left-sided
cancers.81,82 Although colonoscopy is effective in reducing the incidence and mortality of
CRC, the reductions are lower for the proximal (right side) compared to distal cancers.54
It is hypothesized that these differences are attributable to some polyps, like serrated, in
the proximal (right) region being harder to detect. Adenomas and serrated polyps,
specifically sessile serrated, are more likely to be in the proximal colon than distal.83
Large serrated polyps were found to be a strong risk factor for CRC, particularly for
proximal cancers.84 Further, Qumseya et al. found that a right-sided polyp is three times
more likely to have dysplasia (i.e. abnormal cell growth) compared to a left-sided
polyp.85

2.4.3 Age
Advanced age is also a known risk for various chronic diseases like colorectal
cancer. Approximately 90% of diagnosed CRC cases occur in adults 50 years and older,
and over 70% in adults between the ages of 50 and 80 years.86 The number of colorectal
polyps, low and high risk, also increase with age.2,87,88 Therefore, CRC screening exists
primarily in this age range. Although the average age of diagnosis is 69, the CRC
incidence and mortality rate is growing in the younger population, individuals younger
than 50 years old.7 Even though younger patients are more likely to have hereditary
diseases, most of the cases are sporadic with no family history.89,90 Because screening is
not recommended or covered by insurance for average-risk, young adults, this population
tends to be diagnosed after symptoms manifest and in advanced stages.89,91,92 However,
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even when diagnosed in later stages, younger patients have survival at least as good as
older CRC patients.91

2.4.4 Sex
Males have consistently had a higher CRC incidence and mortality rate than
females, even as the overall rates continue to decrease. This is consistent across race, age,
and colorectal sites.93 The median age of diagnosis is 68 for men and 72 for women7, and
a similar mortality age gap is seen across multiple developed nations.94 While men and
women have similar stage at diagnosis, women have a higher 5-year survival, particularly
for individuals under 65 years.95,96 Men also have a higher prevalence of adenomas.83,88
In SC screening cohorts with similar socioeconomic status and health care access, more
adenomas and cancers were detected in men compared to women.97,98
The differences in CRC outcomes can be attributable to differences in biology,
and lifestyle factors. Microsatellite instable tumors have better prognosis than non-MSI
tumors, and are more prevalent in women than men.99 The difference in penetrance of LS
(i.e. women have lower lifetime risk of CRC) was attributable to lifestyle factors like
diet, smoking habits, and estrogen exposure.100 Epidemiologic studies have estimated a
20% reduction in colon and rectal cancer diagnosis and increased CRC survival for
postmenopausal women who ever used hormone replacement therapy.100 Women overall
have a more consistent relationship with a physician, tend to be more knowledgeable
about health literacy, and more willing to participate in CRC screening.101,102 Further,
single men (including those divorced, separated, or widowed) have a lower screening
prevalence than those that are married or in a committed relationship.103
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2.4.5 Race/Ethnicity
Ethnic minorities, particularly African Americans, have a higher incidence and
mortality of CRC compared to White Americans.3 While the burden of disease has
decreased over time, this disparity has remained constant.3,20,26,104 The incidence of CRC
per 100,000 persons was 49.2 for African Americans, 45.7 for American Indian/Alaska
Natives, 40.2 for White, 35.5 for Hispanic, and 32.2 for Asian Americans.7 The disparity
is consistent for CRC mortality as well; per 100,000, there were is 20.5 deaths for African
Americans, 16.4 for American Indian/Alaska Native, 14.6 for White, 11.7 for Hispanic,
and 10.3 for Asian Americans. African American and American Indian/Alaska Natives
are also more likely to be diagnosed at later (distant) stages and have slightly lower 5year survival rates.7
Research has consistently reported the differences in polyp distribution between
African Americans and Whites. African Americans have a higher prevalence of proximal
or right-sided polyps compared to Whites.105–107 These findings are consistent with later
stage diagnosis, and higher incidence and mortality for African Americans. These factors
can be mitigated through regular screening. Screening is known to reduce the incidence
and mortality of CRC108–111, and accounts for approximately 40% of the racial disparities
in these CRC outcomes.86 Screening has increased for all US adults, but the racial
disparities, like incidence and mortality, have remained persistent over time. The 2015
National Health Interview Survey (NHIS) estimates that 61.8% of African American,
54.3% of American Indian/Alaska Native, 65.4% of White, 49.9% of Hispanic, and
54.3% of Asian Americans were up-to-date on CRC screening of any kind.86
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While race is genetically assigned and not modifiable, Simon et al suggested that
disparities in CRC are not racially-related, but rather sociodemographic.112 This is
supported by the fact that, globally, African nations have significantly lower incidence
and mortality rates compared to African Americans.113 In South Carolina CRC screening
programs for low-income and uninsured adults, there was no racial difference in the
prevalence of polyps and adenomas.97,98 Likewise, in the national Prostate, Lung,
Colorectal, and Ovarian Cancer (PLCO) Screening Trial, a similar proportion of African
American and White participants had abnormal flexible sigmoidoscopy reports, however
African Americans were significantly less likely to receive a follow-up colonoscopy
compared to Whites.31 And among those that received the diagnostic colonoscopy, there
were no significant differences in the presence or severity of adenomas. In addition, a
national study on cancer survivorship found that the odds of cost-related medication nonadherence in older African American and Hispanic survivors were over two times the
odds of White survivors.16

2.5 Lifestyle
Maintaining a healthy diet and physical activity (PA) is not only important for
aiding in healthy body weight, but a healthy colon as well. Exhibiting a healthy lifestyle
is the first line of defense in preventing chronic disease. The American Cancer Society
(ACS) recommends that individuals should tailor their diets to maintain a healthy body
weight, limit red and processed meat consumption, eat 2-3 cups of fruits and vegetables
daily, and choose whole grains.114 Research has consistently shown that the regular
consumption of foods high in fiber lowers the risk of CRC.66,115–117 The function of the
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colon is to extract energy through fermentation of undigested food remnants.66 Insoluble
fibers, found in wheat bran foods, balance and control intestinal pH, and increase and
move fecal bulk through the intestines, which reduce mucosal exposure to potential
carcingens.115
Regular PA reduces the risk of chronic disease through the obesity pathway.114
Globally, obese men and women have a higher risk of CRC than non-obese adults.118 PA
is also thought to have a direct impact on CRC as well, like decreasing gastrointestinal
transit time, thus reducing exposure time to carcinogens and lowering insulin levels.119 A
recent meta-analysis estimates an 23% overall risk reduction in CRC for physically active
adults, and an even lower reduction (44%) for adults with no family history.120 Likewise,
a 25% reduction in CRC-specific and all-cause mortality was estimated for pre-cancerous
adults that participated in any PA with an increased protective dose-response effect for
higher levels of PA.121 Similar reductions in CRC incidence and mortality were observed
for adults with higher BMI and smokers.122–124
Cigarette smoking and alcohol consumption are the top modifiable risk factors
attributable to CRC incidence behind physical inactivity, accounting for 11.7% and
12.8% of cancer cases, respectively.75 Longer duration and higher intensity of smoking
were both found to be associated with an increased risk of CRC.125 Along with current
smokers carrying a higher risk than former smokers,126 they also have worse overall and
CRC-specific survival.127 In addition, heavy drinkers, or those that consume a high
volume of alcohol were consistently found to have an increased risk of CRC compared to
non or light drinkers.128–130 More specifically, a national study found that unhealthy
lifestyle factors contribute significantly to the SES disparities seen in CRC risk.131
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2.6 Screening
Screening is considered secondary prevention and is most effective if performed
before disease symptoms arise. In 2010, approximately 63% of CRC deaths were
attributable to lack of screening.132 Average-risk adults are advised to undergo CRC
screening between the ages of 50 and 75. Because sporadic CRC occurs at younger ages
for African Americans, screening begins at age 45 for this population.133 However,
because of the increasing incidence in younger adults, the ACS updated the guidelines
and recommends screening to begin at age 45 for all adults.134 High-risk adults, or those
with a family history, are screened more frequently and begin at earlier ages. There are
various screening modalities that are currently in use by individuals and medical
professionals. These methods can be broken up into three classes, from easy (cost and
administering) to difficult: stool, imaging, and optical tests.

2.6.1 Stool Tests
Stool tests are relatively simple and can be completed without a physician. Stool
tests detect blood in the stool, even if not visually noticeable, because CRC lesions
(benign and cancerous) are more likely to bleed.135 The Fecal Occult Blood Test (FOBT),
Fecal Immunochemical Based Stool Test (FIT), and DNA Stool tests are among the most
popular. FOBT works by using a chemical to detect a component of hemoglobin protein.
Because this component, heme, is contained in some foods, dietary restrictions are
necessary.136 FIT is an improvement to the FOBT because it uses antibodies to detect the
specific hemoglobin protein in humans and requires no dietary restrictions.136 The DNA
stool test use DNA mutations from the cells of the colonic mucosa (lining) as biomarkers

19

for CRC. For the most accurate results, individuals should collect samples from
consecutive bowel movements.135
Although they are less invasive and easy to administer on a large scale, stool tests
have a higher false-positive rate, and they can only detect blood or DNA changes in the
stool, which may be indicative of cancer.137 The U.S. Multi-Society Task Force
(USMSTF) recommends a FIT every year as first-tier option, followed by a DNA stool
test every three years as second-tier for average-risk populations.138 If a stool test returns
positive, it will need to be followed up with a colonoscopy. A randomized control trial
(RCT) comparing FIT, FOBT, and FS found participation rates to be higher for FIT, and
FS detected cancer at a higher rate followed by FIT.139 Similarly, another RCT found a
higher participation rate for FIT compared to colonoscopy, a comparable cancer
detection, but a lower ability to detect adenomas.140 However, the adenoma detection
potential increases for positive-FIT followed by colonoscopy procedures.141,142

2.6.2 Imaging Tests
These tests allow the physician to visualize the colon without having to enter the
colon. In a double-contrast barium enema (DCBE), the patient is given an enema with
barium solution. Then, multiple x-ray images of the entire colon and rectum. A virtual
colonoscopy, or computed tomographic (CT) colonography, uses a CT scanner to take
multiple pictures of the colon and rectum that can show polyps or other abnormalities.
Imaging tests can be more expensive than stool tests, requires no sedation, but still
require a colonoscopy if the tests have abnormal findings. The USMSTF recommends a
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CT colonography every 5 years as a second-tier option for average risk populations.138
The 2018 ACS guidelines does not recommend DCBE as a screening modality.134

2.6.3 Optical Test
Optical tests involve the insertion of a scope through the anus, which requires
stricter bowel preparation. The scope pumps air so the doctor can have a better visual of
the colon. A flexible sigmoidoscopy (FS) uses a sigmoidoscope, a tube with a lens, to
exam the rectum and distal colon. The physician can remove abnormal lesions that were
located for a biopsy. Sedation is not usually required for this test. A colonoscopy
examines the entire colon and rectum and can remove abnormal growths. Because of this,
it is considered the gold-standard of all screening tests.
The USMSTF recommends a colonoscopy every 10 years as the first-tier option,
followed by a FS every 5 years.138 These recommendations are made from consistent
evidence of a beneficial effect. Epidemiologic studies show a 77% and 65% reduction in
CRC incidence and mortality due to colonoscopy, respectively when compared to no
screening.109,143,144 A meta-analysis on endoscopic screening revealed a 31% and 26%
reduction in distal CRC incidence and mortality for FS in randomized control trials
(RCT), respectively, which also included a one-time FS.145 Further, RCT evidence shows
a slightly lowered risk of all-cause mortality after FS screening.146,147

2.7 Surveillance after a CRC diagnosis
The number of cancer survivors continues to increase over time. In 2016, there
were approximately 1.5 million CRC survivors (9% of all cancer survivors), and the

21

proportion is projected to be approximately the same by 2026 representing 1.8 million
survivors.148 After a cancer diagnosis, patients undergo a myriad of events to progress to
survivorship: surgery and treatment regimens, adjustment of lifestyle behaviors, and
coping with the reality of cancer.149 One major adjustment is incorporating surveillance
visits to prevent CRC recurrence. After curative resection of the colon or rectum, the
USMSTF recommends the first surveillance colonoscopy one year after surgery,
followed by a 3-year then 5-year colonoscopy.15 In addition to the this regimen, patients
diagnosed with localized rectal cancer should also receive surveillance through FS every
three to six months for 2-3 years following surgery. One study estimated that only 1861% of CRC survivors received a colonoscopy visit within 12-18 months of surgery.44
The large variability in surveillance rates could be due to the cost. In addition, modifiable
pre-diagnosis lifestyle factors like a healthy diet, PA, and not smoking have shown
evidence in reducing the risk of CRC recurrence and prolonging survival.11,13,121,150

2.8 Endoscopist
Receiving timely CRC screening is imperative in reducing CRC risk, but the
physician that administers these recommended endoscopic procedures also play a role.
Gastroenterologists (GE) are internal medicine physicians that complete additional, ongoing trainings to specialize in endoscopic procedures related to digestive health.
Colorectal surgeons (CRS) are general surgeons that complete additional trainings for
procedures of the colon and rectum. While GEs and CRSs perform a higher volume of
colonoscopies, other physicians in general surgery and primary care (i.e. general internal
medicine and family medicine) also perform colonoscopy.151
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Differences in colonoscopy quality and later colorectal outcomes have been noted
and vary by physician specialty.152–155 While colonoscopy reduces CRC mortality overall,
a national case-control study found that colonoscopies performed by GEs had the lowest
odds of CRC mortality compared to other specialties.156 A population-based Ontario
study found that colonoscopies performed in hospitals by GEs reduced the risk of
incident CRC compared to general surgeons.157 In the Medicare population, patients that
received a colonoscopy from general surgeons or other physicians had 1.3 and 3.0 times
the risk of interval cancer, respectively compared to GEs.158 In addition, CRSs were
found to have better emergency surgery postoperative outcomes159 and lower mortality
rates after rectal surgery160 compared to general surgeons.
Quality measures of colonoscopy like the cecal intubation rate (CIR), adenoma
detection rate (ADR), withdrawal time, and polypectomy rate are associated with
decreased postcolonoscopy CRC (PCCRC),152,161–165 and also vary by endoscopist
specialty. A Canadian study found that surgeons were half as likely to remove polyps that
GEs.153 Likewise, a U.S. study of average risk adults undergoing colonoscopy screening
found that GEs had a higher proximal sessile serrated adenomas detention rate compared
to surgeons.166 In SC, the primary care physicians (PCPs) from the SC Medical
Endoscopy Center receive training from GEs, CRSs, or a board-certified internist, and
assistance from a gastrointestinal technician during the procedure. As a result, the quality
metrics of CIR, polyp detection rate (PDR), ADR, withdrawal time, and minimal adverse
events were comparable to the quality of GEs.167
Endoscopist volume is also related to the quality of the procedure, where quality
metrics improve with the number of colonscopies,168,169 but differ greatly by endoscopist
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specialty.170 Higher endoscopist and hospital volume were both found to be associated
with a lower risk of mortality after colon cancer resection,171,172 and 5-year survival.155 In
the Medicare population, surgeons that performed a very high volume of colon cancer
resections had lower odds of postoperative complications.173 However, in a group of
general surgeons, higher volume was not associated with the ADR.169

2.9 Environmental Influences
2.9.1 Socioeconomic status
It has been said that socioeconomic status (SES) and zip code predicts our later health
outcomes more than our genetic code. Epidemiologic studies have consistently shown
that people with lower income have lower overall health, more hospitalizations, lower
screening rates, and an overall lower life expectancy.174–177 Numerous factors like lower
health literacy and limited access to healthy food outlets contribute to these disparities.178
For example, a systematic review found low health literacy to be associated with less
preventative visits, higher emergency room utilization, and a contributor to racial health
disparities.179 The screening rate for CRC increases for every level of higher education as
well as insurance status.86 When considering CRC incidence by poverty level, the
decreasing trend applied to mainly moderate to high income areas.180

2.9.2 Geographic location
Public health literature consistently recognizes geographic location as determinant
of health. The built environment influences and affects the decisions that people make
about their health. In particular, geographic distance can be a barrier to accessing health-
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promoting opportunities and receiving health care.181 Individuals that live further from
health facilities have lower screening rates182–184 and experience delayed or no care185,186.
In addition, individuals that have less access or greater travel distance to care are often
diagnosed with cancer at later stages187–189 and have a higher mortality rate190–192. Some
studies have also found geographic distance to PA opportunities and healthy food outlets
create negative outcomes and inequities in health. In particular, residents with more
access to supermarkets and limited access to convenient stores and fast food restaurants
tend to have healthier diets and lower prevalence of obesity.35 When multiple social
determinants like race, SES, and geographic distance are interacting, CRC outcomes can
be compounded.23,193
Rural families tend to be at the disadvantage as it relates to geographic distance
and health. Compared to rural residents, urban residents have more flexibility in choosing
a health facility, more access to specialists, and shorter travel distances.194 For example,
having more GEs reduced the delay in diagnosis in rural areas, but had no effect in urban
areas.195 There are larger clusters of health services and specialty doctors in urban areas
compared to rural.196 National studies reveal that as the level of rurality increase, the
density of physicians decrease, with the most drastic declines in the proportion of
available specialists.197,198 Particularly in SC, many of the endoscopists performing
colonoscopy primarily practice in urban areas, which include 87% of GEs and 100% of
CRSs.151 Thus, rural residents travel farther for overall care and CRC-related
services.184,199,200 As a result of these differences in access to care, rural residents have
lower screening rates.22,197,201
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2.9.3 Obesogenic Environment
An obesogenic environment is defined as the sum of influences that the
surroundings, opportunities, or conditions of life have on promoting obesity in
individuals or populations.202 Chaput et al. noted that many of our modern comforts like
readily available, high calorie food are counter to our natural biology.203 Obesity is a
natural response to obesogenic environments.204 For example, a national study found the
number of fitness centers and natural amenities to be negatively associated with obesity,
while a higher number of fast food restaurants positively associated.205 Lower income
areas suffer the most harm from obesogenic environments. In particular, lower income
neighborhoods were found to have a higher density of fast food outlets compared to
higher income neighborhoods.206
There have been mixed findings about the relationship between the obesogenic
environment and cancer. Canchola et al. found that traffic density was inversely
associated with CRC risk in African American and Latino residents, but positively
associated with White Americans.40 Conroy et al. found that mixed-land development
was positively associated with breast cancer risk in Latino women, but negatively
associated with White women.207 However, these studies did not find a significant
association between the food and recreational environment with cancer, even with a large
sample size. Therefore, it is possible that the obesogenic environment does not have a
direct impact on cancer risk but operates through other pathways.
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CHAPTER 3
METHODS
3.1 Data Sources
3.1.1 SC Ambulatory Surgery Discharge Database
The SC Ambulatory Surgery Discharge Database is an all-payer, populationbased ambulatory outpatient database for endoscopic procedure claims in South Carolina
between 2000 and 2014. The procedures (colonoscopy or sigmoidoscopy) were identified
by the ICD-9 and/or HCPCS procedure code (see Appendix A). The de-identified
database was constructed by the Revenue & Fiscal Affairs Office in Columbia, SC in
2017. Each claim (row) contains information about the patient, facility of procedure, and
the physician(s) performing the procedure. The patient-level data include: a unique
identifier, the month and year of the admission, diagnostic code(s), procedure code(s),
payor, age group, race, sex, state, county and Zip code. The facility-level data include:
name, address, county, and type. The physician-level data include: SC license number(s),
physician National Provider Identification (NPI) number, and medical specialty. The
2009 and 2013 SC Medical Board licensing directory and the 2017 NPI registry were
used to supplement physician specialty information.

3.1.2 Colorectal Cancer Prevention Network (CCPN)
In 2008, the Center for Colon Cancer Research at the University of South
Carolina established the CCPN, a statewide screening program that promotes education
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and awareness of CRC. The CCPN is a collaborative effort of patient navigators, boardcertified gastroenterologists, licensed pathologists, and cancer treatment specialists.
Eligibility for the program include: uninsured adults aged 50 – 64 (45 for African
Americans) that lived at or below 150% of the federal poverty line and receive care from
safety-net practices (like FQHCs and FMCs). Exclusion criteria include: having a
colonoscopy within the last 10 years, symptoms of CRC, personal history of cancer, and
other gastrointestinal-specific criteria. Colonoscopies were performed by board certified
gastroenterologists, and diagnoses were confirmed by contracted pathologists. Data
collection in this screening cohort includes over 1,000 variables about patient
demographics, personal/family history, health behaviors, and clinical outcomes. The
clinical outcomes include the colonoscopy results, quality metrics, and may include a
pathology report about the findings of any cancer or lesions. More information about the
CCPN can be found elsewhere.97

3.1.3 South Carolina Central Cancer Registry (SCCCR)
The SCCCR contains records for individuals diagnosed with cancer and living in
SC from 2000 to 2014. For these aims, only a colorectal (colon or rectum) cancer
diagnosis is relevant. This database contains demographic and clinical for data for each
patient. The demographic information includes: sex, race, age, county, rurality, 2000 and
2010 patient ZCTA, census tract poverty indicator, and unique identifier. The clinical
information include month and year of diagnosis, cancer sequence number, primary site,
behavior, histology, stage, grade, laterality, cause of death, death status, survival time.
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3.2 Paper 1
3.2.1 Study Population
The SC Ambulatory Surgery Discharge Database will be used to identify unique
patients that visited a center for a screening colonoscopy between 2010 – 2014. To isolate
screening procedures, patients will be excluded if younger than 50 and older than 75
years, had a previous CRC cancer diagnosis, a documented personal history of CRC,
more than one colonoscopy within a 3-year period, or received an emergency
colonoscopy. Personal history will be assessed based on procedure codes from the
discharge database, and we will determine a previous cancer diagnosis by crossreferencing patient identifiers in the SCCCR.

3.2.2 Analysis
We will create facility catchment areas (CAs) for each colonoscopy facility in SC
based on the location (i.e., ZIP code centroid) of patients seeking screening
colonoscopies from each respective facility. For each facility, we will create a dataset
with patient demographic data, which includes sex, race, age group, insurance, and ZIP
code. To estimate the proportion of patients (from each ZIP code) that chose to visit a
given facility (n = 98), we will utilize hierarchical Bayesian logistic regression as laid out
by Wang and Wheeler.208 The patient ZIP code will capture the residual effect after
adjusting for demographic variables. The overall logistic model is:
log
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where pij is the probability of person j from ZIP code i receiving a screening
colonoscopy, and vi is the ZIP code-specific random effect. The random effect is
expected to capture the remaining heterogeneity of each ZIP code, like the rurality, local
policies and norms, and socioeconomic features. The reference group is female sex, white
for race, the 50 – 59 group for age, and commercial/HMO for insurance.
To fit the hierarchical Bayesian logistic model, we will use R2jags in R version
3.5.2. The exceedance probability for assigning a ZIP code to a CA will be q = 0.95. The
exceedance probability is estimated by calculating the number of ZIP code odds ratios
(ORs) from the posterior samples that exceed one. We will map the CAs to illustrate the
regions that do not fall in any catchment area (Figure 1). We will also create tables with
descriptive statistics to compare the demographics of patients inside and outside the CAs
(Table 2) and the effect of the variables on the CAs (Table 3) of select facilities.

3.3 Paper 2
3.3.1 Study Population
This aim will utilize the CCPN data and the cohort that was screened between
January 1, 2014 and August 31, 2018.

3.3.2 Obesogenic Environment Score
The obesogenic environment score is the exposure of interest and will be
constructed using county and census tract data such as the median household income,
food environment (retail, food deserts), neighborhood safety, and park availability. This
score is currently in development by Principal Investigators Kaczynski and Eberth as part
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of a cooperative agreement with the Health Resources and Services Administration
(HRSA). The obesogenic environment score will be calculated at the county and census
tract level using data from 2012 – 2014. The CCPN database will be merged to the
obesogenic environmental score by the patient’s county of residence at time of
enrollment in the CCPN Program.

3.3.3 Outcomes
The outcomes of interest are 1) presence of any histologically-confirmed polyp or
adenoma and 2) presence of any histologically-confirmed high-risk polyp or adenoma.
High risk polyps are defined as any polyp 1 cm or greater, including hyperplastic, any
traditional serrated or sessile serrated adenoma/ polyp, any polyp w/villous components,
and/or high-grade dysplasia.97 Low risk is considered to be all other polyps. Covariates of
interest are age, sex, race, education, family history of CRC, obesity status (body mass
index or waist-to-hip ratio), smoking history, alcohol consumption, comorbidities,
urban/rural status, and area-level income.

3.3.4 Analysis
For this aim, we will estimate the effect of the obesogenic environment on the
presence of polyps (overall and high-risk) through mediation analysis, where the
mediator is obesity. We will use the mediation approach built from the counterfactual
theory that incorporates exposure induced confounders (See Figure 3.1).209 In addition,
we will perform a sensitivity analysis to estimate the unmeasured effect of diet since this
is an important confounders were either unmeasured or unreliable.
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We will construct a table of demographics of the CCPN cohort of all participants,
those with polyps, and those with high-risk polyps (Table 1). An additional table with the
mediated effects, the controlled, direct, direct, and the total effect (Table 2). This table
will house results for both outcomes (all polyps and high-risk polyps).

Income/SES
Physical
Activity
Obesogenic
Environment

Diet

Obesity

Polyp (s)
C

Figure 3.1. Directed acyclic graph illustrating the relationship between the obesogenic
environment and polyps through obesity.

3.4 Paper 3
3.4.1 Study Population
The SC Ambulatory Surgery Discharge Database and the SCCCR will be merged
to only include patients between the ages of 18 and 75 diagnosed with colorectal cancer
between January 2001 and June 2013. Persons diagnosed in distant stage cancer, <65
years with Medicare, with an inflammatory condition, and death before the surveillance
window will be excluded.

3.4.2 Outcome
Colonoscopy records between 2001 and 2014 for those diagnosed with cancer
will be linked to the patient records to create the main outcome variable: adherence to the
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1-year surveillance colonoscopy. It will be a binary variable (yes or no). The 1-year
window is measured as 9 – 18 months after date of CRC diagnosis.

3.4.3 Analysis
We will use multivariate log binomial regression to model the prevalence ratio of
adherence to surveillance colonoscopy within one year. An interaction term between age
and race will also be tested to directly address this aim. Covariates include sex, primary
insurance, stage at diagnosis (local or regional), tumor site (colon or rectum) and
residential location (urban vs. rural). Descriptive statistics will be calculated and
compared by adherence status (Table 1). In bivariate analyses, we will use the Chi-square
test for categorical covariates and t-tests for continuous covariates. A model results table,
stratified by age group, will present the effect of the variables on the surveillance (Table
2). Finally, we will calculate the age-adjusted prevalence of surveillance adherence over
the study period and construct a figure to illustrate the trend overall and by race and sex
(Figure 1).
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CHAPTER 4
CATCHMENT AREA ANALYSIS FOR COLONOSCOPY CENTERS IN SOUTH
CAROLINA1

1

Josey MJ, McLain A, Merchant AT, Eberth JM to be submitted to Health & Place
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4.1 Abstract
Colorectal cancer (CRC) is the third most common cancer in adults but is mostly
preventable through a healthy lifestyle and screening procedures like colonoscopy. While
colonoscopy can be a life-saving procedure, obstacles like lack of awareness and distance
to care, particularly for rural residents, continues to be a barrier. The purpose of this study
was to explore the geographic distribution of colonoscopy services by creating catchment
areas (CAs) around each colonoscopy facility in South Carolina (SC).
We used the SC Outpatient Ambulatory Surgery Database to identify adults who
received a screening colonoscopy between 2010-2014. Adults were included if they were
between the ages of 50-74 and living in SC and excluded if they had a personal or
suspected history of CRC or CRC-related diseases. We performed catchment area (CA)
analysis using 2-stage Bayesian hierarchical logistic regression, with a ZIP code random
effect. We repeated this model for all colonoscopy facilities in SC.
Of the 98 colonoscopy facilities, 96 had at least one ZIP code within its CA and
covered 88% of ZIP codes in SC. Many ZIP codes, particularly those in metropolitan
areas, were included in 2-3 CAs. Only 2% of patients resided in a ZIP code that fell
outside of a CA, which were mostly along the state border.
The colonoscopy facilities reached a large portion of SC. While this study was on
the actual utilization of patients that chose to be screened, the distance and other nonspatial barriers may still be present in the unscreened population.
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4.2 Introduction
Colorectal cancer (CRC) is the third most common cancer in both men and
women, and was estimated to be the 2nd leading cause of cancer death in South Carolina
for 2018.210 However, CRC is mostly preventable through regular screenings and a
healthy lifestyle, which could advert 58% and 50% of incident CRC cases in men and
women, respectively.75 The U.S. Multi-Society Task Force (USMSTF) on CRC
recommends colonoscopy as the primary tier procedure for CRC prevention because it
can remove lesions from the colon, thus reducing or eliminating the potential for
cancer.138 Research has shown that colonoscopy prevents an estimated 77% of CRCrelated deaths.109,143,144
Although colonoscopy can be a life-saving procedure, only 68% of age-eligible
adults have received any CRC screening, with state-level rates as low as 50 - 60%, with
adults aged 50 – 64 having the lowest rates.7 The USMSTF recommends that adults
participate in screening from age 50 through 75.138 Barriers to screening, particularly for
colonoscopy, include lack of awareness, cost, distance to care, and negative views about
the procedure.8–10 While there have been improvements in public awareness and cost,
distance continues to be a barrier, particularly for rural residents. People that live in rural
areas travel a longer distance to colorectal screening and care, and have almost twice the
travel time compared to urban residents.184,199 Amongst other factors, this obstacle
manifests in higher incidence and mortality for rural residents.33,211
With largely preventable diseases like CRC, national committees set goals to
increase screening utilization and reduce mortality rates. For example, HealthyPeople
2020 published a goal for 70.5% of recommended eligible adults to be up-to-date with
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CRC screening guidelines by 2020.212 More recently, the National Colorectal Cancer
Roundtable set a goal for 80% of eligible adults to be up-to-date with screening by 2018
and encouraged local agencies and health facilities to partner with the mission by taking a
pledge to action.213 While these initiatives spark enthusiasm, they also draw attention to
the issue of CRC screening capacity and handling an influx of new customers. In a
simulation study, Joseph et al. found that in the first year, a colonoscopy-only screening
program would require 16.2 million colonoscopies across the United States, with the
maximum capacity (current and unrealized) being enough to handle the demand.214 While
capacity may be adequate nationally, some counties and states have found mixed results
in their ability to handle the growing demand.215,216 A study in Arizona found that urban
and rural counties could increase their capacity by 36% and 53%, respectively, but only
the urban counties needed more manpower to realize the maximum. In South Carolina
(SC), the number of centers performing colonoscopy and the annual physicians volume
of colonoscopies has noticeably increased in urban areas, but remained constant or
declined over time in rural areas.151 Therefore, it is necessary for researchers and health
care providers to know the geographic distribution of services as well as target areas for
potential growth, where services are most underutilized and where resources can be
shared or expanded. One way to make inferences on the capacity of health care services
is to investigate the spatial distribution of available resources and the potential consumer
demand. In the healthcare field, a catchment area (CA) is a geographic region that
contains a population of people that are more likely to utilize services at a specific health
facility. A simple CA may include the population of people that live within a 30-minute
or 30-mile buffer of the facility. However, this method assumes that people that do not
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live in close proximity will not use the services. CA analyses continue to grow in
complexity by taking into account commuting and public transportation,217,218 urban
versus rural driving normalcy,219,220 and competing businesses221.
We implemented a Bayesian Hierarchical method proposed by Wang and
Wheeler that does not limit a CA to a specific distance or time boundary.208 This is
particularly important because these factors may not be as important when seeking
elected, specialty services like colonoscopy, particularly in regions outside of major cities
where driving is the most feasible mode of transportation. Therefore, individuals that are
willing to travel farther have a chance to be included in the CA. In addition, many CA
methods estimate the potential accessibility, however this method allows for
retrospective, patient-level data to estimate the realized accessibility. Another aspect of
this CA analysis is that it can quantify and illustrate where individuals choose to get a
colonoscopy, and how their demographic characteristics affect the formation of each CA.
Currently, the literature is limited for CA analysis of healthcare facilities,
particularly colonoscopy centers. Much of the current literature in the United States
revolves around primary care facilities as opposed to specialty services. The purpose of
this project is to illustrate and describe the catchment areas (i.e. service areas) of facilities
in SC providing screening colonoscopies from 2010 – 2014, and the travel patterns of
their patients. Using data from the population-based SC Outpatient Ambulatory Surgery
Database, we examined travel patterns of age-eligible adults seeking a colonoscopy in
SC. Specifically, our study aimed to identify areas within the state that underutilize
colonoscopy screening and describe the characteristics of patients within (or outside)
existing CRC screening facility CAs.
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4.3 Methods
4.3.1 Data source
We used the all-payer, population-based SC Outpatient Ambulatory Surgery
Database (ASD) for the years 2010 – 2014. This individual-level database houses
demographic, insurance, zip code, and county data for colonoscopy patients, the SC
license information and specialty code for physicians, and the name and address of the
facility where the procedure was performed. The type of endoscopic procedure was
classified using ICD-9, CPT, and HCPCS codes (see Appendix A). Only colonoscopy
procedures were retained for this study.

4.3.2 Study population
The target population was adults living in SC that were eligible for a screening
colonoscopy. The patients in this study were between the ages of 50 and 74, which is the
recommended age range for colonoscopy screening. To isolate the screening-eligible
population, patients were excluded if they were diagnosed with cancer prior to the
colonoscopy or had more than one colonoscopy within a 3-year window because these
patients are more likely to be on a more intense, surveillance regime. Patients were also
excluded if they received a colonoscopy in the emergency room, which indicates a
diagnostic or non-elected procedure.

4.3.3 Colonoscopy facility
Any SC facility performing at least one colonoscopy procedure for the screeningeligible population between 2010 and 2014 was eligible for inclusion in this study.
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4.3.4 Statistical Analysis
We utilized the method presented by Wang and Wheeler, specifically a 2-stage
Bayesian hierarchical logistic regression.208 Our model estimates the probability, pij that a
patient received a colonoscopy at a particular facility (yes or no). The model included a
ZIP code random effect so we could estimate the residual variation in the odds of being
screened at a facility after adjusting for demographic variables. For a ZIP code to be
considered for inclusion in a CA, at least one patient from that ZIP code had to visit a
colonoscopy facility. Therefore, if no one received a colonoscopy, all patients from that
ZIP code was dropped from the analysis. The logistic regression model was:
log
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where / is the random effect of ZIP code j for patient i. The priors for the β coefficients
were chosen to be non-informative from the Normal distribution with mean zero and
precision of 0.00001 (which is equivalent to standard deviation of 1 × 105). The prior on
the random effect was Normal with mean zero and precision τ, where the prior on τ was
also chosen to be non-informative from the Gamma distribution with parameters a = 0
and b = 0.0005. We used two chains with 15,000 iterations each, a burn-in period of
10,000 samples per chain, and a thinning rate of 2, resulting in a total of 5,000 posterior
samples. The starting values for the first chain was zero for each α and β coefficient, and
1 for τ. The starting values for the second chain was -1 for each α and β coefficient, and
10 for τ. We repeated this process for each colonoscopy facility in SC.
To determine if a ZIP code was included in a CA, we used a threshold exceedance
probability, qj. The exceedance probability is the number of times the odds ratio (OR) for
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ZIP code j from the Monte Carlo Markov Chain (MCMC) posterior samples (after burnin) exceeded one. We chose qj ≥ 0.95, which means: at least 95% of the ORs from the
MCMC samples were greater than one, which indicates that the association between ZIP
code j and the facility is larger than average after adjusting for the covariates (these are
similar to hypothesis tests that the random effects are greater than zero). Our choice of qj
was more stringent than the conventional threshold chosen by Wang and Wheeler to try
to capture ZIP codes that are truly included in a CA.208 We also performed a sensitivity
analysis using a range of thresholds (0.85, 0.90, 0.95).
The demographic variables included in the model were binary indicators for age
group, sex, race, and insurance type. The reference level for each variable was 50 – 59
age group, female, white, and commercial/HMO insurance. To reduce the collinearity
between age and insurance, a public insurance category was created that included
Medicare and Medicaid. We also compared the patients and results by rurality status.
Rurality was categorized using the 2010 Rural-Urban Commuting Area (RUCA) Codes
by the United States Department of Agriculture. RUCA codes categorize areas based
upon their population density and commuting patterns.222 Patients were classified as
either urban (codes 1.0, 1.1, 2.0, 2.1, 3.0, 4.1, 5.1, 7.1, 8.1, 10.1) or rural (4.0, 5.0, 6.0,
7.0, 7.2, 8.0, 8.2, 9.0, 10.0, 10.2, 10.3). The univariate associations with the covariates
and being included in a CA were compared using the Chi-Square test and the Wilcoxon
Sum-Rank (because of skewness) test for continuous covariates. The Bayesian
hierarchical logistic models were fit and the maps created using the R2jags package and
ggplot2 package, respectively in R version 3.5.2. The complete address for each facility
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(street, city, zip) was geocoded in ArcGIS Pro with a match rate of at least 98.6%, and
the ZIP code shapefile was publicly available and provided by ESRI.223

4.4 Results
There were 394,816 adults included in our study. Most of the colonoscopy
patients were aged 60 – 69 (68%), female (56%), White (65%), used commercial/HMO
insurance (53%), and resided in an urban ZIP code (93%); see Table 4.1. Only 9120 (2%)
of patients resided in a ZIP code that was not included in a CA. The distance of the
chosen colonoscopy facility was approximately two times the distance of the closest
facility (5.71 vs. 11.86 miles), with rural patients traveling a greater distance, particularly
for rural patients not within a CA. The age and sex demographic distribution of patients
outside of a CA was similar to those within a CA. However, there was a larger proportion
of White patients not included in CA (77% vs. 65%) and distribution of rural patients not
included in a CA was significantly smaller (0.4% vs. 7%).
Between 2010 and 2014, there were 98 facilities that performed an average of 813
(SD = 802) screening colonoscopies per year. The CAs included 476 different ZIP codes,
covering 88% of ZIP codes in SC. The average number of ZIP codes within a CA was 16
and ranged from zero to 63. Having zero ZIP codes in a CA means that a facility has no
CA or had a very low chance of patients within those ZIP codes being screened there. On
average, the longest distance patients within a CA traveled to the utilized facility was 8.7
miles. The mean CA size increased slightly between the current cutoff value qj = 0.95 and
0.85 to 18 ZIP codes, and the maximum distance traveled stayed consistent at 8.9 miles in
the sensitivity analysis. Facilities located in urban counties collectively reached 87% of
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ZIP codes compared to 75% for rural facilities. Of the 62 ZIP codes not included in a CA,
15% were rural and clustered in the Midlands and Lowcountry counties bordering
Georgia, which was similar to the overall distribution of rural ZIP codes in SC (13%).
Figure 4.1 shows the distribution of catchment areas of facilities performing
screening colonoscopies in SC, where darker colors indicate more overlap of the CAs.
Many of the colonoscopy facilities were clustered in urban areas with the darker shading,
particularly the Charleston, Greenville, and Columbia metropolitan areas. Approximately
53% of the ZIP codes fell within 2-3 CAs, and ZIP codes with the most overlap (i.e. 12
CAs) were surrounding or within the most populated areas of SC like Richland and
Charleston counties.
Table 4.2 shows a summary of the odds ratios of the variables included in the
model for a sample facility in SC with a particularly large CA. Black patients and patients
classified as Other race were significantly less likely to come to this facility (Black: OR =
0.42, 95% Confidence Interval (CI): 0.40, 0.44; Other race: OR = 0.04, 95% CI: 0.03,
0.04) compared to White patients. Those with public insurance were 29% less likely to
come to this facility (OR = 0.71, 95% CI: 0.68, 0.75) and those with other insurance had
25% lower odds of coming to this facility (OR = 0.75, 95% CI: 0.70, 0.79) compared to
those with commercial/HMO insurance. This facility provided one of the highest annual
volumes, and provided colonoscopy services to patients from across SC.

4.5 Discussion
This study quantified and illustrated the CAs of centers providing screening
colonoscopies in South Carolina using hierarchical Bayesian logistic regression. The CAs
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of the colonoscopy facilities covered most ZIP codes in SC, overall and for urban and
rural facilities separately. ZIP codes located in or near larger cities within the state had
the most overlap and fell within multiple CAs. The CA sizes varied with most facilities
having a large reach and span of customers across their county.
Like many specialty services, colonoscopy providers were clustered in urban
areas. Although the facilities may compete for consumers, the CAs of these facilities
overlap the surrounding population without a clear distinction. Wan et. al used a threestep catchment area method to address overestimation of clustered facilities and identify
shortage areas.221 Using the actual utilization of colonoscopy patients, our study was able
to handle clustered facilities and identified shortage areas, which were mainly located
along the edges of the state (i.e. edge-effect). This may not indicate underuse of
colonoscopy screening because some of these patients may choose to go to an out-ofstate facility in neighboring counties, which may be closer in distance and possibly
covered by their employer and associated insurance plan. This is supported by our data; a
larger proportion of patients in our study with commercial insurance were located outside
of a CA than within compared to those with public insurance. In addition to the ZIP
codes along the edges, ZIP codes that were comprised mainly of businesses (e.g. hospital
and universities) were not estimated to be a part of any CAs, even if it was near a
colonoscopy facility.
Previous literature has shown that rural areas have more barriers to receiving care
than urban residents.196,224 While rural patients in our study must travel farther for a
colonoscopy, most patients from rural ZIP codes that chose to be screened were within at
least one CA. McGrail and Humphreys used multiple distance buffers to account for rural
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travelers.219 Without presetting distance thresholds, our study identified multiple CAs that
rural ZIP codes fell within, with a wide range of travel distances. While the patients in SC
seeking a colonoscopy had the ability to bypass their closest facility, the CAs for the
facilities generally represented the ZIP codes in closest proximity.
The implications of this study lay the groundwork for understanding the screening
capacity and accessibility of physicians performing colonoscopy in SC. A physician
being physically available does not imply access. For the same population, a study
estimated the density of colonoscopy providers by adjusting for annual volume and
down-weighting physicians that performed few procedures per year.225 There were two
facilities that did not have a CA, although they were identified as a colonoscopy facility.
Thus, a simple count of physicians or facilities would overestimate the supply of
physicians and facilities performing colonoscopy. In addition, a deeper investigation of
the association of patient demographics on visiting a facility would further elucidate nonspatial barriers. Although most ZIP codes were included in at least one CA, inclusion
does not indicate barriers or burden of travel. The patients in this study are those that
chose to be screened and do not account for the 31% of eligible residents in SC that were
not up-to-date with any CRC screening.86 Future studies should consider the age-eligible
population and their demographics to account for the unrealized potential.
There are a few limitations to consider. The purpose of this data was billing of
administrative claims, and the accuracy was dependent on those coding the data.
However, this dataset was extremely large, and thus more robust to non-systematic errors
in original data. We were also unable to include out-of-state patients in our analysis
because we did not have complete information about colonoscopy utilization of
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neighboring states, although they were present in the original data. Thus, measuring
capacity for screening colonoscopy should consider cross-state health seeking activity.
By linking databases across state lines, future studies can quantify the additional demand
of out-of-state patients. Also, the CA formation was dependent on a subjective cutoff
value. We chose to use a more conservative value than the conventional value,208 yet the
results were similar and have a higher sensitivity, which was desired. Despite these
limitations, using the population-based, all-payer ASD, this is the first study to quantify
CAs for colonoscopy facilities for an entire state. Future studies should consider how
CAs change as the health insurance landscape continues to evolve, specifically for
screening or preventative procedures.

4.6 Conclusion
The reach of current facilities performing screening colonoscopies span the state
of SC, leaving only a small proportion of residents outside of a CA. Urban facilities
provided colonoscopy services for most SC patients. Yet, the presence of rural facilities
remains important to serving current demands of rural residents, as well as the growing
future capacity.

Table 4.1. Characteristics of patients seeking a screening colonoscopy in South Carolina,
2010 – 2014
Characteristic
n (%)
Age
50 – 59
60 – 69
70 – 74

All patients
394816 (100)

In CA
385696 (98)

Outside CA
9120 (2)

p-value

99825 (25)
268696 (68)
26295 (7)

97288 (25)
262695 (68)
25713 (7)

2537 (28)
6001 (66)
582 (6)

<0.001
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Sex
Male
Race
Black
White
Other
Insurance
Commercial/HMO
Public
Medicare
Medicaid
Other
Rurality
Rural
Distance (miles)
Nearest facility
Urban
Rural
Chosen facility
Urban
Rural

174839 (44)

170553 (44)

4286 (47)

<0.001

73591 (19)
256759 (65)
64466 (16)

71825 (19)
249724 (65)
64147 (17)

1766 (19)
7035 (77)
319 (3)

<0.001

211756 (54)
152729 (39)
142300 (36)
10429 (3)
30331 (8)

206250 (53)
149500 (39)
139305 (36)
10195 (3)
29946 (8)

5506 (60)
3229 (35)
2995 (33)
234 (3)
385 (4)

<0.001

26336 (7)

26296 (7)
40 (0)
Mean (SD)
5.71 (5.07)
5.69 (5.09)
6.61 (4.03)
5.53 (4.92)
5.50 (4.94)
6.60 (4.03)
8.26 (6.24)
8.26 (6.25)
8.86 (3.50)
11.86 (12.23) 11.92 (12.26) 9.16 (10.5)
11.32 (11.72) 11.37 (11.75) 9.03 (10.2)
19.39 (12.14) 19.36 (16.11) 43.71 (22.15)

<0.001
<0.001
<0.001
0.129
<0.001
<0.001
<0.001

Footnotes: Distance was calculated as the straight-line distance from the ZIP code centroid to
the colonoscopy facility. CA – Catchment Area

Table 4.2. Odds ratios of patient demographics for a sample facility in South Carolina.
Coefficient
Male
Black
Other race
Age 60 – 69
Age 70 – 74
Public Insurance
Other Insurance

Odds Ratio
0.91
0.42
0.04
1.05
1.25
0.71
0.75
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95% CI
(0.87, 0.95)
(0.40, 0.44)
(0.03, 0.04)
(1.00, 1.10)
(1.14, 1.38)
(0.68, 0.75)
(0.70, 0.79)

Colonoscopy facility

Figure 4.1. Map of the 98 colonoscopy facilities and their catchment areas in South
Carolina, 2010 – 2014.
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CHAPTER 5
THE OBESOGENIC ENVIRONEMNT AND COLORECTAL POLYPS: A
MEDIATION ANALYSIS APPROACH2

2

Josey MJ, Merchant AT, LaFrance D, Eberth JM, Caldwell R, Thibault A to be submitted to BMC Public
Health
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5.1 Abstract
Adenomatous polyps, or abnormal growths in the colon or rectum lining, account
for 96% of all CRCs. While individual behaviors like smoking and poor diet play a role
in the development of colorectal polyps, the environment also contributes to cancer
outcomes. The obesogenic environment is a neighborhood-level measure of obesitypromoting attributes, and the relationship with CRC has mixed findings in the literature.
The purpose of this study was to explore the pathways between the obesogenic
environment and colorectal polyps.
The participants from this study were screened by colonoscopy through the
Colorectal Cancer Prevention Network, a program for low-income, uninsured adults
living in SC. Adults were included if they were 50-64 (or 45-64 for African Americans).
We used mediation analysis to decompose the natural direct effect (NDE) and natural
indirect effect (NIE) of the obesogenic environment on colorectal polyps through obesity.
We considered both general and high-risk polyps as outcomes. We also ran a sensitivity
analysis to adjust for unmeasured confounding.
Of the 959 participants included in the study, 63% and 15% had at least one polyp
or high-risk polyp, respectively. The NDE for having a high-risk polyp was 0.74 (0.44,
0.99) for full-service restaurants. Obesity did not mediate the relationship between the
obesogenic environment and colorectal polyps. The sensitivity analysis revealed that the
food environment becomes more protective as unmeasured confounding increases.
Most of the obesogenic environment did not reduce the risk of having colorectal
polyps. While people may not be able to move to a better environment, creating a healthy
lifestyle within any community can offset the neighborhood-level influences.
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5.2 Introduction
Colorectal cancer (CRC) is the third most common cancer and the second leading
cause of cancer death in the United States (U.S.).210 In 2013, an estimated 800,000
person-years of life lost was due to CRC.226 However, a healthy lifestyle and regular
screening CRC can reduce occurrence of new cases and CRC-related deaths.1,6,7
Approximately 90% of new CRC cases and deaths occur in adults aged 50 and older,
respectively.86 Thus, the Multi-Society Task Force on CRC recommends screening for
the average-risk population aged 50 – 75 years. Nationally, the CRC screening
prevalence has increased for this group, from 52% in 2008 to 67% in 2014.227,228
However, an estimated 63% of CRC deaths in 2010 were attributable to non-screening.132
Research shows a 77% and 65% reduction in CRC incidence and mortality,
respectively due to receipt of at least one colonoscopy.143,144 Colonoscopy is the primary
(first tier), recommended modality for cancer prevention due to its ability to remove
potentially cancerous legions or polyps.134,138 Polyps are precursors to CRC and vary in
size and location, where each contributes to the severity and development of CRC.
Hyperplastic polyps are very common, but rarely develop into cancer,49 while
adenomatous polyps account for 96% of all CRCs.7 Some lifestyle behaviors are
associated with the development of polyps. For example, smoking was shown to increase
the risk of serrated polyps, a highly malignant adenoma that accounts for 30% of CRCs.52
In addition, poor diet, particularly those lacking fiber, and a lack of physical activity are
hypothesized to increase the risk of CRC.66,116,117 Higher fiber diets and physical activity
decrease the transit time of fecal bulk in the intestines, which reduces the exposure time
of potential carcinogens on the colon lining.115,119
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While individual behaviors play a role in the development of CRC, the
environment has also been shown to contribute to various cancer outcomes. Pesticides,
radiation, fibers and dust, metals, and second-hand smoke have been found to be
associated with an increased risk of multiple cancers, particularly organs in the
respiratory system.229 Beyond influences of the physical environment, the “built
environment” has more recently been investigated for its role in the development of
cancer. People are nested within their communities, and while they are mobile, the ability
to participate in health-promoting opportunities is often dependent on their immediate
environment. For example living in a more walkable neighborhood was associated with
higher physical activity levels.230 Better access to healthy food (e.g. from grocery stores
or supermarkets) and limited access to convenience stores has been associated with
healthier diets and healthier weight.35 Disparities arise because healthy food tends to be
more expensive and lower income and rural residents live further from healthy food and
closer to fast food.231
The obesogenic environment is a measure of neighborhood-level obesitypromoting attributes, such as high density of fast food restaurants and fewer grocery
stores and physical activity locations. Obesity is strongly correlated with CRC,2,232 with
obese adults having a 20% higher risk of developing CRC than non-obese adults.232
Obesity was also estimated to be attributable to 5.2% of CRC cases.75 Figure 1 shows our
hypothesized, literature-supported relationship between the obesogenic environment,
obesity, having at least one polyp identified during a screening colonoscopy.
There is a gap in the literature about the relationship between the obesogenic
environment, individual level obesity, and CRC. A national study found traffic, vehicle
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transit, and more restaurants to be associated with an increased risk of CRC in some
ethnic subgroups.40 Further, the association between the obesogenic environment and
precursors to CRC (i.e. polyps) has yet to be quantified. This study proposes to consider
the bigger picture of the relationship between the obesogenic environment and polyp risk.
Research consistently supports the path from the obesogenic environment to obesity,207 as
well as the path from obesity to the presence of colorectal polyps.120,233 However, the
path through obesity has yet to be quantified (see indirect pathway in Figure 3.1). While
people that live in an obesogenic environment may develop CRC through obesity, this
study seeks to determine if there is a direct effect of the environment on CRC
independent of individual-level obesity. Using a standardized population that controls for
many SES factors like income and insurance access, we will address the following aims:
1. Examine the pathways between the obesogenic environment and the presence of
CRC polyps.
2. To explore whether the association of the obesogenic environment on the
presence CRC polyp(s) differs by polyp type (any and high-risk).
Hypotheses:
1. The pathway between the obesogenic environment and having a polyp is mostly
mediated through obesity.
2. The direct pathway (not through individual-level obesity) has a stronger effect on
high-risk polyps than the general class of polyps.
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5.3 Methods
5.3.1 Study Population
The participants from this study were screened through the Colorectal Cancer
Prevention Network (CCPN), a program established by the Center for Colon Cancer
Research at the University of South Carolina as a strategic method to reduce CRC
morbidity and mortality disparities in SC. The CCPN is a navigation program that
provides free colonoscopy screenings to low-income, uninsured adults by partnering with
Free Medical Clinics and Federally Qualified Health Clinics throughout the state. The
program utilizes the services of board-certified gastroenterologists, pathologists, and
cancer treatment specialists. Additional information about the CCPN is available
elsewhere.97
To be eligible for inclusion in the CCPN, potential participants had to be aged 50
– 64 or 45 – 64 for African Americans, live at or below 150% of the federal poverty line,
and uninsured. This analysis included CCPN participants who had a colonoscopy
between January 2014 and August 2018. Individuals were excluded if they had a
colonoscopy within the past 10 years, a personal history CRC, recently experienced
CRC-related symptoms, a known history of inflammatory bowel disease, or a personal
history of cancer other than skin cancer. CCPN gastroenterologists can also exclude
individuals from screening based on other personalized factors such as morbid obesity.
The program guidelines are in alignment with the U.S. Multi-Society Task Force
recommendations for CRC screening of the average-risk population.138
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5.3.2 Mediation
Valeri and Vansteelandt (2009) introduced a causal mediation analysis method
using the counterfactual approach to decompose and estimate the controlled direct,
natural direct, and indirect effects of an exposure on an outcome.234 In this study, the
controlled direct and natural direct effects are equivalent because we do not believe that
there is an interaction between the obesogenic environment and obesity. The controlled
direct effect (CDE) is the average difference of having a polyp had all the participants
lived in a highly obesogenic environment versus if all participants lived in a lower
obesogenic environment across all obesity levels. Similarly, the natural direct effect
(NDE) is the average difference of having a polyp had all the participants lived in a
highly obesogenic environment versus if all participants lived in a lower obesogenic
environment, and all participants were not obese. The natural indirect effect (NIE) is the
average difference of having a polyp had all the participants lived in a highly obesogenic
environment then became obese versus living in a highly obesogenic environment and
not becoming obese. The same interpretations hold for high-risk polyps.
The assumptions for this causal mediation analysis are: no unmeasured
confounding between the exposure and outcome, exposure and mediator, mediator and
outcome, and none of the mediator-outcome confounders are induced (or caused) by the
exposure. However, because diet is unmeasured, sensitivity analyses are necessary to
estimate the possible effect on the results (Figure 3.1). The remaining variables in the
minimally-sufficient set to control for confounding are income/SES, and the variables
included in C. Because our population is restricted to low-income, uninsured adults in
SC, this is a feasible model to estimate.
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5.3.3 Exposure
The main exposure for this study is the obesogenic environment. The obesogenic
environment index (OEI) was created by a team of researchers at the University of South
Carolina in a project funded by the Federal Office of Rural Health Policy on childhood
obesity. The process of constructing the index began with compiling area-level variables
from a comprehensive literature review, then verifying them in an expert review. Ten
final variables that were potentially associated with childhood obesity were included in
the index, nine at the county level and one at the state level. The publicly available
variables were the availability of: grocery stores and superstores, farmers markets, fast
food restaurants, full service restaurants, convenience stores, exercise opportunities,
school proximity, walkability, violent crime, and births at baby-friendly facilities (statelevel). Grocery stores/superstores, farmers markets, births at baby-friendly hospitals,
exercise opportunities, school proximity, and walkability were hypothesized or
previously shown to be inversely related to obesity and were reversed coded so that lower
OEI meant a healthier environment. The variables were then ranked and allocated a
percentile, where 0 = least obesogenic/healthy and 100 – most obesogenic/unhealthy. The
final county-level OEI was the average percentile across all non-missing variables. Only
6% of U.S. counties had missing data (1, 2, or 3 variables), with zero missing data for SC
counties. We assumed that the patients lived in the same or a county with similar
exposure levels during the polyp development period.
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5.3.4 Mediator
The mediator was whether the participant was obese. Obesity status was
determined by the standard definition of having a body mass index (BMI) greater than 30
kg/m2. Measurement of height and weight were self-reported and compared to measures
from recent office visits within 7 – 30 days of the colonoscopy.

5.3.5 Outcome
The primary outcomes were 1) the presence of any histologically-confirmed
colorectal polyp or adenoma (yes/no) and 2) the presence of any histologically confirmed
high-risk polyp or adenoma. High risk polyps are defined as any polyp one cm or greater,
including hyperplastic, any traditional serrated or sessile serrated adenoma/ polyp, any
polyp w/villous components, and/or high-grade dysplasia.97 If participants did not have a
subpathology report, they were removed from the high-risk polyp analysis (n = 237).

5.3.6 Confounders
The variables considered for entry in the model were age at program inclusion,
sex, race/ethnicity, highest attained education, family history of CRC, smoking history,
alcohol consumption, non-steroidal anti-inflammatory drugs (NSAIDs) usage, physical
activity, income level, and urban/rural designation. Age was categorized as 45-49, 50-54,
55-59, and 60-64. Race/ethnicity was classified as Non-Hispanic Black, Non-Hispanic
White, or other. Education was categorized as: less than high school (HS), GED or HS
diploma, some college or Associate’s degree, or Bachelor’s degree or higher. Family
history of CRC was determined if the participant reported having a mother, father, or
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sibling ever diagnosed with CRC. NSAID utilization was indicated by NSAID or aspirin
usage and categorized as daily, 4 – 6 days, 1 – 3 days, or zero days per week. Physical
activity (PA) was measured as the number of days during the last week spent doing no,
moderate, or vigorous physical activity. We categorized PA to be in close alignment with
the standards for PA; whether a participant was moderately or vigorously active for zero
days, 1-3 days, 4-6 days, and 7 days per week.
Smoking status was categorized using the CDC definition for never, former, and
current smoker.235 Alcohol consumption was also determined by the CDC.236 Heavy
consumption was defined as having greater than 14 and 7 drinks per week for men and
women, respectively. Moderate consumption was having no more than two drinks and
one drink per day (which we expanded to ≤14 and ≤7 per week) for men and women,
respectively. And no consumption was zero drinks per week. ZIP code level median
household income was obtained from the 2007-2011 American Community Survey, an
ongoing survey performed by the U.S. Census Bureau that provides area-level
sociodemographic information and categorized into tertiles.237 Urban/rural status was
determined using the ZIP code approximated 2010 Rural-Urban Commuting Area
(RUCA) Codes by the United States Department of Agriculture. RUCA codes categorize
areas based upon their population density and commuting patterns.222 A participant was
considered an urban resident if their ZIP code RUCA was metropolitan (RUCA = 1.0,
1.1, 2.0, 2.1, 3.0, 4.1, 5.1, 7.1, 8.1, 10.1) and rural otherwise. Participants were excluded
if they were missing any covariate (n = 30).
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5.3.7 Statistical Analysis
We used the chi-square test for categorical variables in the univariate analysis.
The mediation analysis utilized the product method described by Valeri and
VanderWeele to estimate the decomposition of effects (direct and indirect) of the
exposure on the outcome.238 The confidence intervals were estimated using 1000
bootstrap samples. We used logistic regression to estimate the effect of the exposure on
the mediator (obese vs. not obese) and loglinear regression to estimate the effect of the
exposure and mediator on the outcome (polyp vs. no polyp). The parameter estimates
from the two models were used to estimate the natural direct effect (NDE) and the natural
indirect effect (NIE), which were interpreted as relative risks (RR). A sensitivity analysis
for unmeasured confounding of a mediator-outcome confounder was conducted using a
method proposed by Vanderweele and Chiba.239 The sensitivity analysis explores how the
estimates would change over values of the expected relationship between the exposure,
mediator, and all measured and unmeasured confounders on the outcome. We categorized
the composite OEI and individual variables by classifying each as ‘high’ if greater than or
equal to the 75th percentile and low otherwise. All variables in the OEI were in the
analysis except availability of baby-friendly hospitals because it was a state-level variable
and does not vary among participants in SC. Data management was carried out in R
version 3.5.2 and analysis was carried out using the mediation macro in SAS by Valeri
and VanderWeele.238
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5.4 Results
The final sample included 959 adults that had a colonoscopy within the study
period. Table 1 shows that most the study population was aged 50-54 (44%), nonHispanic Black (53%), obtained a high school diploma (42%), lived in an urban ZIP code
(84%), had no family history of CRC (94%), and lived in a low-level obesogenic
environment (73%). Many of the participants were also current (39%) or never smokers
(40%), consumed moderate levels or no alcohol (47% each), were obese (51%), and
either never took NSAIDs (32%) or took at least one NSAID daily (31%). The overall
polyp detection was 63% and was higher in males (68% vs. 60%; p < 0.01), urban
residents (65% vs. 54%; p = 0.02), current smokers (p < 0.001), and heavy drinkers (p =
0.044). The high-risk polyp detection was 15% and did not vary by any demographic or
lifestyle variables.
The mediation analysis revealed that features of the obesogenic environment were
not associated with having any colorectal polyp. For high-risk polyps, the NDE was 0.74
(95% CI: 0.44, 0.99) for full-service restaurants and non-significant for the remaining
index and composite variables. Obesity did not mediate the association between the
obesogenic environment and having a polyp or high-risk polyp.
The sensitivity analysis revealed that as the (realistic) differences in the outcome
of having a polyp increased between the exposed and unexposed populations, the direct
effect became stronger and more protective across the food environment, specifically
grocery store and convenience store availability. The difference in the proportion of
having a polyp across the exposure levels amongst obesity groups had to be at least 10%
for the residual confounding to reduce the risk of polyps. Farmers markets and restaurant
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access required stronger differences. The direct effect remained null across the physical
activity environment and the overall composite score. For the high-risk polyps, the
difference in the outcome by exposure and mediator required for the residual
confounding to affect the risk of polyp was complex for many of the obesogenic
variables. The food environment had similar findings as general polyps, however, fast
food restaurant access only required a 1% difference. Access to PA locations and the
composite OEI reduced the risk of high-risk polyps when differences were at least a 5%.
As the difference in the outcome increased across the exposure populations (1%), the
indirect effect of the exposure on the outcome through the obesity increased for all polyp
types, increasing the risk of having a polyp.

5.5 Discussion
Full-service restaurants had an unexpected direct and preventative effect on
having a high-risk polyp. Obesity did not mediate the relationship between the individual
variables or composite OEI on the risk of having a polyp. However, the sensitivity
analysis showed how accounting for unmeasured confounding increased the strengths of
the associations. Therefore, our hypotheses were somewhat confirmed in this study.
Rather, elements of the obesogenic environment seem to have an independent effect on
risk of polyps in this low-income, uninsured population.
Grocery/superstore availability has been hypothesized to be associated with
positive health outcomes, although there have been mixed findings in the literature.35,240
Cummins et al. found that after the establishment of a new grocery store, dietary habits of
residents remained unchanged.241 Likewise, a longitudinal study found that grocery store
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availability was unrelated to changes in fruit and vegetable consumption.242 Restaurants
tend to be clustered in urban areas,231 so it is possible that these associations are
indicative of the type of neighborhood and its associated assets that might contribute to
more positive health outcomes (e.g., density of primary care physicians). Our study
included area-level income and rurality; future studies could explore how the obesogenic
environment affects the risk of polyps when considering the individual distance to food
and the PA environments.
There have been various findings about the relationship between physical activity
and CRC.124,244 Epidemiologic studies suggest that physical activity could prevent CRC
by reducing or maintaining a healthy body weight, or improving circulation and
metabolism.75,114,119 Boehmer et al. found that the being located farther from physical
activity locations and feeling unsafe due to crime to be associated with obesity.245
Another study found that non-socially isolated adults that lived in areas with more access
to physical activity locations were less likely to be physically inactive.246 Through the
sensitivity analysis, we found that having a higher availability of physical activity
locations could potentially reduce the risk of high-risk polyps. Future studies on the
obesogenic environment and cancer should also consider the social networks of
individuals because the social environment can be more influential than the geography of
the built environment.247
In this population, the polyp detection rate (PDR) for overall and high-risk for
obese participants was slightly lower compared to the normal weight participants. This
may be unique to the low-income, uninsured population, as overweight and obese adults
overall tend to have more polyps than normal weight adults.248–250 This dynamic directly
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affected the overall results of the study. Previous research have reported mixed findings
about the availability of food outlets and body weight, noting that residential access to
various types of food outlets does not encompass the total utilized food resources (e.g.
while at work or in transit).243 Similarly, Fuzhong et al. found that positive OEI features,
like walkability, was associated with a decrease in body weight, while negative features
like fast food restaurants, was associated with an increase in body weight, among those
that utilized these outlets.242 In our sensitivity analysis, we found that when accounting
for unmeasured confounding, particularly individual diet, obesity mediated the
relationship of the exposure on the outcome by increasing the risk of having a polyp, as
the difference in the outcome across the exposure levels increased. In addition, we found
that aspects of the food environment were possibly protective of colorectal polyps.
There are a few limitations to consider. Our data did not include information on
individual diet patterns. However, we were able to include a sensitivity analysis that
accounted for unmeasured confounding to find that the food environment may have a
stronger effect on the risk of having a polyp. We also used county-level data to measure
the area-level obesogenic environment. While counties are macro-level in nature, we
were able to find a significant effect on the outcome. Future studies could utilize smaller
areas to measure the neighborhood obesogenic environment, or a GIS approach to
capture individual proximity. Despite these limitations, the CCPN cohort is ideal for
making causal inferences on colorectal outcomes because it was a controlled population
where many barriers to accessing colonoscopy were removed. The CCPN cohort also
represents a hard-to-reach population, and more likely to contribute to those with higher
incidence and mortality in SC, thus these estimates are extremely meaningful.
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5.6 Conclusion
Although the obesogenic environment is thought to be obesity-promoting, obesity
did not mediate the effect of the environment on the odds of having polyp in a controlled
population. There were direct effects of the environment on colorectal polyp risk. While
people may not be able to move to a better environment, creating a healthy lifestyle
within any community can offset neighborhood-level influences. Obesity is not the sole
measure for health status, so future studies should examine the additional ways that the
obesogenic environment affects CRC outside of the commonly studied pathways.

Table 5.1. Characteristics of participants and polyp detection in the CCPN Program,
January 2014 – August 2018.

Characteristic
No. of participants (%)
Demographics
Age
45 – 49
50 – 54
55 – 59
60 – 64
Sex
Male
Female
Race
Non-Hispanic Black
Non-Hispanic White
Other
Education
Less than High School
High School Diploma
Some college/Associate’s degree
Bachelor’s degree or higher
ZIP code-level income ($)
≤ 35,297
≤ 43,133

Overall
Population
959

46 (4.0)
422 (44.0)
300 (31.3)
191 (19.9)
378 (39.4)
581 (60.6)
507 (52.9)
399 (41.6)
53 (5.5)
250 (26.1)
405 (42.3)
243 (25.4)
60 (6.3)
338 (35.3)
305 (31.8)

64

Polyp Detection
High-risk
Any polyp
polyps a
606 (63.2)
114 (15.8)
p = 0.2642
31 (67.4)
252 (59.7)
198 (66.0)
125 (65.5)
p = 0.0058
259 (68.5)
347 (59.7)
p = 0.4499
311 (61.3)
260 (65.2)
35 (66.0)
p = 0.1815
167 (66.8)
254 (62.7)
154 (63.4)
31 (51.7)
p = 0.0467
197 (58.3)
206 (67.5)

p = 0.3149
3 (8.1)
45 (14.2)
40 (17.7)
26 (18.3)
p = 0.2404
54 (17.6)
60 (14.4)
p = 0.3899
53 (14.1)
53 (17.3)
8 (20.0)
p = 0.1576
38 (20)
39 (12.6)
29 (16.0)
8 (20.5)
p = 0.1832
45 (18)
39 (16)

≤ 77,901
316 (33.0)
203 (64.2)
30 (12)
p = 0.1340
Rurality
p = 0.0205
Urban
801 (83.5)
519 (64.8)
91 (14.9)
Rural
158 (16.5)
87 (55.1)
23 (20.5)
p
=
0.1090
p
= 0.3213
Family History of CRC
No
903 (94.2)
565 (62.6)
104 (15.4)
Yes
56 (5.8)
41 (73.2)
10 (20.8)
p = 0.5219
p = 0.2033
Obesogenic Environment
Low
703 (73.3)
440 (62.6)
88 (16.9)
High
256 (26.7)
166 (64.8)
26 (13.0)
Lifestyle
p = 0.2568
Smoking status
p < 0.001
Never
386 (40.3)
215 (55.7)
35 (13.1)
Former
196 (20.4)
122 (62.2)
24 (16.0)
Current
377 (39.3)
269 (71.4)
55 (18.1)
p = 0.8478
Alcohol Consumption
p = 0.0436
None/Low
454 (47.3)
277 (61.0)
51 (15.3)
Moderate
450 (46.9)
286 (63.4)
55 (15.9)
Heavy
55 (5.7)
43 (78.2)
8 (18.6)
p = 0.5334
p = 0.3345
Obesity
Underweight
11 (1.2)
9 (81.8)
0
Normal weight
172 (17.9)
111 (64.5)
26 (19.6)
Overweight
288 (30.0)
184 (63.9)
32 (14.5)
Obese
488 (50.9)
302 (61.9)
56 (15.6)
p
=
0.0978
p
= 0.7740
NSAID Use
None
303 (31.6)
202 (66.7)
38 (16.0)
Occasionally
184 (19.2)
117 (63.6)
21 (15.8)
1 – 3 days/week
129 (13.5)
86 (66.7)
19 (19.8)
4 – 6 days/week
48 (5.0)
33 (68.8)
6 (15.8)
Daily
295 (30.8)
168 (57.0)
30 (13.8)
Procedure Quality
p = 0.4914
p = 0.7936
Bowel Preparation
Excellent/Good
868 (92.1)
551 (63.5)
101 (15.3)
Fair/Poor
74 (7.9)
44 (59.5)
8 (16.7)
a
Footnotes: This number is based on the 722 participants that had a subpathology report.
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Table 5.2. Decomposition of effects of the obesogenic environment on having a polyp

Obesogenic Environment Index
Any Polyp
Food Environment
Grocery Stores
↓
Farmers Markets
↓
Convenience Stores
↑
Full-Service Restaurants ↑
Fast Food Restaurants
↑
Physical Activity Environment
School Access
↓
PA Access
↓
Walkability
↓
Violent Crime
↑
Composite Score
↑
High-Risk Polyp
Food Environment
Grocery Stores
↓
Farmers Markets
↓
Convenience Stores
↑
Full-Service Restaurants ↑
Fast Food Restaurants
↑
Physical Activity Environment
School Access
↓
PA Access
↓
Walkability
↓
Violent Crime
↑
Composite Score
↑

Decomposition of Effects (RR)
NDE
NIE
Total Effect

0.92 (0.81, 1.00)
0.97 (0.87, 1.08)
0.94 (0.74, 1.02)
1.01 (0.93, 1.09)
1.00 (0.92, 1.07)

1.00 (0.99, 1.00)
1.00 (0.99, 1.00)
1.00 (0.99, 1.01)
1.00 (0.99, 1.01)
1.00 (0.99, 1.00)

0.92 (0.81, 1.00)
0.97 (0.87, 1.08)
0.94 (0.74, 1.02)
1.01 (0.93, 1.09)
1.00 (0.92, 1.07)

1.04 (0.97, 1.14)
0.99 (0.90, 1.08)
1.05 (0.97, 1.15)
1.02 (0.93, 1.10)
1.01 (0.93, 1.09)

1.00 (0.99, 1.01)
1.00 (0.98, 1.00)
1.00 (0.99, 1.01)
1.00 (0.99, 1.01)
1.00 (0.99, 1.00)

1.04 (0.97, 1.14)
0.98 (0.90, 1.08)
1.05 (0.97, 1.15)
1.02 (0.93, 1.10)
1.01 (0.93, 1.09)

0.91 (0.60, 1.27)
0.91 (0.54, 1.35)
0.86 (0.53, 1.17)
0.74 (0.44, 0.99)
0.78 (0.49, 1.03)

1.00 (0.98, 1.02)
1.00 (0.98, 1.02)
1.00 (0.98, 1.03)
1.00 (0.96, 1.03)
1.00 (0.98, 1.02)

1.26 (0.77, 1.96)
0.91 (0.54, 1.35)
0.86 (0.53, 1.17)
0.74 (0.44, 0.99)
0.78 (0.49, 1.02)

1.04 (0.68, 1.51)
0.86 (0.53, 1.21)
1.05 (0.70, 1.51)
0.99 (0.67, 1.39)
0.84 (0.53, 1.14)

1.00 (0.96, 1.03)
1.00 (0.97, 1.02)
1.00 (0.96, 1.03)
1.00 (0.99, 1.02)
1.00 (0.99, 1.01)

1.04 (0.68, 1.51)
0.86 (0.53, 1.20)
1.04 (0.70, 1.48)
0.99 (0.67, 1.39)
0.84 (0.53, 1.14)

Footnotes: * p < 0.05, ** p < 0.001
The logistic and loglinear models used to calculate the natural direct effect (NDE), natural indirect effect
(NIE), and the total effect (TE) adjusted for sex, smoking status, weekly alcohol consumption, NSAID use,
ZIP code-level income and rurality. The controlled direct effect (CDE) = NDE since both the exposure and
mediator are binary. The decomposed effects are interpreted as risk ratio (RR). The high-risk mediation
analysis was based on the 722 participants that had a subpathology report. The arrows represent the
expected direction of the association on having a polyp.

66

CHAPTER 6
INCREASED INSURANCE ACCESS AND SURVEILLANCE OF COLORECTAL
CANCER3

3

Josey MJ, McLain A, Merchant AT, Eberth JM, Schootman M. Submitted to Cancer Causes & Control,
7/18/19
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6.1 Abstract
Surveillance colonoscopy is recommended one year after a colorectal cancer
(CRC) diagnosis and treatment to prevent cancer recurrence, but uptake is suboptimal
and understudied among minority populations. We examined whether racial disparities in
adherence to surveillance are less pronounced over time in older (age 65+) versus
younger CRC survivors (age <65) due to improved access to health insurance.
We linked colonoscopy records from the population-based, all-payer SC
Outpatient Ambulatory Surgery Database from 2001-2014 to the SCCCR to identify
those diagnosed with a primary CRC from 2001-2013. We calculated the age-adjusted
prevalence of one-year surveillance and used multivariable loglinear regression to model
the prevalence ratio of adherence to colonoscopy within one year (9-18 months) after
CRC diagnosis. Covariates included race, sex, primary insurance, stage at diagnosis and
urban/rural status. The final model was stratified by year of diagnosis (2001-2007 and
2008-2013) to determine if disparities persist over time.
Among the 9016 survivors included in the study, 5041 (56%) received a
colonoscopy within 1-year of diagnosis. The difference in adherence between White and
Black survivors fell from 9.2% to 3.7% for men and 8.9% to -1.0% for women from 2002
to 2013. Among younger male survivors, the prevalence of adherence was 14% lower in
Black versus White survivors over time. However, the disparity was no longer present in
the older survivors in the later years.
The disparity in receiving a 1-year surveillance colonoscopy diminished over time
between Black and White survivors, but younger Black male survivors remained at
increased risk of recurrence due to lower surveillance colonoscopy adherence.
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6.2 Introduction
Colorectal cancer (CRC) is the third most common cancer in the United States
(U.S.) and the third leading cause of cancer death in both men and women in 2018.1 The
recent decline in CRC incidence and mortality has been attributed to increased screening
and improved treatment.2 The 5-year survival rate has also increased over time, ranging
from 14% for distant stages to 90% for localized stages.3 Although there are overall
improvements in morbidity, mortality, and late staging of CRC, racial and socioeconomic
disparities in CRC outcomes persist.4,5
The burden of a cancer diagnosis does not necessarily end with treatment. Cancer
survivorship begins when a person is diagnosed and continues until death. In 2016, there
were approximately 1.5 million CRC survivors in the U.S.,6 a 25% increase from 2012.7
In addition to coping with a life-altering disease, life after a cancer diagnosis includes a
plethora of changes including treatment, interacting with new doctors, adjusting to a
wellness plan, and handling financial stresses.8 The Institute of Medicine and the
National Research Council name prevention, surveillance, intervention, and coordination
as essential components of survivorship care in the health care delivery system.9 For CRC
survivors in the U.S., having health insurance is imperative to begin to navigate this
system and help alleviate the added financial stress. For example, in the U.S., the average
out-of-pocket cost of a colonoscopy is $3000,10 a cost that is typically absorbed under the
Affordable Care Act when it is considered a preventive, screening procedure. However,
for diagnostic or surveillance procedures including post-CRC colonoscopy, individuals
may face high deductibles and cost-sharing with their insurance. Research has shown that

69

ethnic minorities are less likely to receive cancer follow-up care,11 and face more
financial hardship during survivorship12.
The U.S. Multi-Society Task Force on CRC recommends a surveillance
colonoscopy one year after curative resection (treatment) of the colon or rectum,
followed by a three-year and five-year colonoscopy.13 Observational studies and
randomized controlled trials found surveillance colonoscopies to be associated with
reduced CRC recurrence and improved overall survival.13 A systematic review in 2013
found that 18 – 61% of survivors received a post-treatment colonoscopy within 12 – 18
months.14 Adherence to surveillance colonoscopy among specific subgroups is not as
well-studied as screening adherence,15,16 therefore disparities have also yet to be
quantified. While there have been improvements in CRC screening uptake over time,
these results cannot simply be extrapolated to CRC surveillance. While many states have
established CRC screening programs and insurance coverage is more comprehensive for
screening, few have done so focusing on surveillance following cancer diagnosis.
The purpose of this study was to determine adherence to guideline-concordant
surveillance colonoscopy, overall and by racial subgroup, over time in South Carolina.
We hypothesize that the disparity between older (65+ years) Black and White CRC
survivors will be significantly reduced compared to younger CRC survivors (<65 years)
due to increased access to health insurance coverage (i.e. Medicare benefits).
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6.3 Methods
6.3.1 Data Sources
The South Carolina Ambulatory Surgery Database (ASD) is a retrospective,
longitudinal population-based data set of outpatient procedures performed in SC. Using
ICD-9 and HCPCS codes (in Appendix A.1), we identified records indicating
colonoscopy between 2001 and 2014. This database provides patient demographic and
procedure information like age, race, sex, insurance, county, zip code, and colonoscopy
date. The South Carolina Central Cancer Registry (SCCCR), one of the National Program
of Cancer Registries, contains records on all individuals diagnosed with cancer in SC. In
addition to demographic characteristics, the registry has clinical data like age at
diagnosis, stage, location, grade, laterality, cause of death, and survival time.
The ASD was merged with the SCCCR by a unique, de-identified patient
identifier to determine if a cancer patient received a colonoscopy after CRC diagnosis.
The ASD database was constructed and merged with the SCCCR by the South Carolina
Revenue & Fiscal Affairs (RFA) Office in 2017.

6.3.2 Study Population
The target population for this study was adults living in SC that were diagnosed
with a primary CRC between January 2001 and June 2013. Survivors were included if
they were adults between the ages of 18 and 75. This upper age limit coincides with the
current CRC screening guidelines; there is no standard for surveillance colonoscopy in
elderly patients; it is based on the individual life expectancy.17 Individuals were excluded
if they were diagnosed with in-situ or distant stage CRC according to SEER stage, as the
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surveillance recommendations were based on patients in stages I – III.13 Individuals were
also excluded if they were younger than 65 years and their primary payer was Medicare
because these patients tend to be less healthy prior to a diagnosis due to co-occurring
disease such as end-stage renal disease (ESRD). We also excluded individuals that died
before the end of the surveillance window. Finally, individuals were excluded if
diagnosed with an inflammatory condition (e.g. Crohn’s disease, ulcerative colitis,
irritable bowel syndrome) to reduce the likelihood of accounting for patients that had a
total colectomy.

6.3.3 Outcome
The outcome of interest was whether an individual received a colonoscopy 1 year
after a CRC diagnosis (yes/no). The 1-year window was measured as 9 – 18 months after
CRC diagnosis to allow for scheduling difficulties and post-diagnosis clearing
procedures.

6.3.4 Statistical Analysis
We used multivariable log binomial regression to model the prevalence ratio (PR)
of adherence to the 1-year surveillance colonoscopy. An interaction term between age (at
diagnosis) and race was included to assess if there are differences in the adherence
prevalence. We divided the study window into two (semi-equal) time periods to
determine if racial disparities were consistent over time: diagnosis year between 20012007 or 2008-2013. Demographic covariates included were sex, primary insurance
(Commercial/HMO, Medicare, Medicaid, Other), and rurality (urban vs. rural). Race was
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categorized into Black, White, or Other. The final model considered all race by sex
subgroups, as heterogeneity exists within these groups,3,18 however model results for
‘Other’ race will not be reported due to the small sample size. Rurality was defined using
the 2003 Rural-Urban Continuum Code (RUCC) Codes by the United States Department
of Agriculture. A survivor was considered an urban resident if their county RUCC was
considered metropolitan or urban (RUCC = 1,2,3) and rural otherwise (RUCC=4-9).
Clinical covariates were stage at diagnosis (local or regional), and primary cancer site
(colon or rectum).
Because both the ASD and SCCCR are population-based databases, including a
near census of colonoscopies provided and cancers diagnosed in SC, we calculated the
age-adjusted prevalence of surveillance adherence for each year using the Surveillance,
Epidemiology, and End Results Program (SEER) guide for calculating age-adjusted
rates.19 The adherence prevalence was measured for the year following the diagnosis. We
calculated the prevalence for the overall population and by race and sex subgroups from
2002 – 2013. Differences in demographics variables were calculated using the Chi-square
test, and the significance level was 0.05.

6.4 Results
There were 8,869 patients included in the final sample (Figure 1). The ageadjusted prevalence of adherence to the 1-year surveillance colonoscopy post-diagnosis
was 55.7% for CRC survivors in SC across the entire study period and remained stable
over time; 57.0% in 2002 to 54.0% in 2013 (ptrend = 0.17). White survivors had a
significantly higher prevalence of adherence compared to Black survivors across the

73

study period (58.2% vs. 50.0%, p < 0.001). Over time, the racial difference in
colonoscopy adherence by sex diminished. Figure 2 shows that adherence difference
between White and Black men fell from 9.0% in 2002 to 3.0% in 2013 (ptrend = 0.10). For
women, the difference between White and Black survivors fell from 9.4% in 2002 to 0.7% in 2013 (ptrend = 0.002; see Appendix B.1).
Table 1 shows that survivors residing in urban areas had a higher adherence
prevalence compared to rural survivors (57.6% vs. 51.4%, p < 0.001), and those with
Other insurance or that self-paid for the procedure had a lower prevalence compared to
commercial/HMO and Medicare (p < 0.001). Those diagnosed with colon cancer were
more likely to adhere compared to rectal cancer survivors (p < 0.001), and a higher
proportion of survivors that received the 1-year colonoscopy were alive at the end of the
study (p < 0.001).
The interaction between race and age was significant in the log binomial model (p
< 0.001). Table 2 shows that Black male survivors were approximately 13% less likely to
adhere to the 1-year surveillance colonoscopy compared to White males for the younger
age group across both time periods. Older Black males were less likely to adhere
compared to White males in the early study period [PR = 0.73, 95% Confidence Interval
(CI): (0.62, 0.87)] but were no different in the later years [PR = 1.01 (0.86, 1.18)].
Younger Black females were less likely to adhere to the surveillance colonoscopy in the
early years compared to White men [PR = 0.82 (0.73, 0.92)], but were no different in the
later years [PR = 0.98 (0.88, 1.10)]. There were no significant differences between older
Black women or White women overall compared to White men.
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Younger survivors that self-paid were less likely to adhere compared to those with
commercial/HMO insurance for the early years [PR = 0.72 (0.61, 0.85)] and the later
years [PR = 0.85 (0.74, 0.98)]. For the older age group, there were significantly fewer
survivors that self-paid and no difference was detected compared to commercial/HMO
insurance.

6.5 Discussion
This study quantified the prevalence of adherence to surveillance colonoscopy
after CRC diagnosis over time and determined if increased access to health insurance
reduced racial disparities in colonoscopy adherence. Over half (56.0%) of CRC survivors
received their first surveillance colonoscopy within the recommended timeframe. This
study showed that young White survivors had a higher prevalence of adherence and were
more likely to receive a colonoscopy compared to young Black (male) survivors,
regardless of the time period. However, this disparity was eliminated for the older age
group (65+ years) in the later end of the study period, supporting our hypothesis of
diminished racial disparities in the older population.
In comparison to our estimated SC statewide adherence rate (56%), a study using
electronic medical records of health systems across various states also found that 55% of
CRC survivors received a colonoscopy within 18 months of curative surgery.20 Overall, it
is difficult to compare studies because of different study settings and analytic designs.
For example, a cancer institute in Alberta, Canada observed an adherence rate of 67%
where their study participants were enrolled in a surveillance program.21 Older national
studies report large racial disparities in receiving a surveillance colonoscopy for both the
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Medicare-eligible and younger populations.22,23 Our study shows the reduction in these
disparities over time and also reflects how surveillance uptake has increased over time,
particularly for older Black survivors, but not yet for younger Black survivors.
Our results show the powerful role that insurance can play in the health care
delivery system. Survivors younger than 65 years that self-paid were less likely to adhere
compared to all other insurance types. While disparities diminish when opportunities are
available, access to health insurance is not always enough to completely remove the
financial burden that comes with being a cancer survivor. For example, Lee and Salloum
found that Black and Hispanic survivors were two times more likely to experience costrelated medical non-adherence compared to White cancer survivors.12 Under the
Affordable Care Act, colonoscopies for high-risk individuals, particularly those with a
personal history (i.e. survivors), will more than likely have to share the cost of the
procedure.24
There are limitations of this study to consider. There was no available individuallevel socioeconomic (SES) variable in the cancer registry or ambulatory surgery
discharge database. When using surrogate SES variables at the aggregate level, like the
census tract poverty index, the values were similar across adherence groups and were not
significant in a univariate model. However, primary insurance is highly correlated with
household income,25 and was included in the models. It is possible that an accurate
measure of individual SES is a true confounder and explains the remaining difference in
prevalence by race. A Veteran’s Affairs study found that White veterans were 32% less
likely than Black veterans to receive a surveillance colonoscopy within 7 – 18 months.26
In addition, we were unable to disentangle whether patients had a total colectomy and
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needed a surveillance colonoscopy. However, survivors included in the study were
diagnosed in local and regional stages and no record of an inflammatory disease. Total
colectomy is mainly an option for adults with inflammatory diseases or genetic
conditions, which represents a very small proportion of CRC cases.27 We were unable to
include CRC survivors in the model if they had no colonoscopy record in the ambulatory
surgery discharge database, which houses their insurance information. This could include
CRC survivors receiving their surveillance colonoscopies out-of-state or within the
Veteran’s Affairs healthcare system. However, this only accounted for 7% of the total
cancer registry records within the study period and this is unlikely to explain our
findings.

6.6 Conclusion
This study highlights reductions in racial disparities in surveillance colonoscopy
following CRC diagnosis. Closing the surveillance adherence gap is instrumental in
reducing the overall burden of CRC. Access to health insurance coverage seems to play a
role in these improvements. Future studies should monitor surveillance adherence
following CRC as the landscape of insurance availability and cost continues to evolve in
the U.S. It is possible that future changes could help improve utilization in younger Black
men.
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Table 6.1. Baseline characteristics of adults diagnosed with CRC from 2001 – 2013.

Characteristic
Demographic
Sex
Male
Female
Age
18 – 64
65 – 75
Race
White
Black
Other
Primary Insurance
Commercial/HMO
Medicare
Medicaid
Self-Pay
Other
Rurality
Urban
Rural
Census Tract Poverty
<5%
5 – <10%
10 – <20%
20 – 100%
Clinical
Stage
Local
Regional
Primary Site
Large Intestine
Rectum
Alive at study end

Adherence
Prevalence
(95% CI)
56.0 (54.9, 57.0)

Adhered
n (%)
4964 (56.0)

Did not
adhere
n (%)
3905 (44.0)

p-value

0.041
54.9 (53.0, 56.9)
57.1 (55.1, 59.1)

2561 (51.6)
2403 (48.4)

2101 (53.8)
1804 (46.2)
0.017

57.1 (55.3, 58.9)
54.5 (52.3, 56.7)

2913 (58.7)
2051 (41.3)

2192 (56.1)
1713 (43.9)
<0.001

58.2 (56.6, 59.7)
50.1 (47.2, 53.0)
50.0 (37.8, 62.2)

3766 (75.9)
1143 (22.8)
64 (1.3)

2710 (69.4)
1131 (29.0)
64 (1.6)
<0.001

58.5 (56.5, 60.4)
56.1 (53.8, 58.4)
52.3 (45.8, 58.9)
45.4 (38.3, 52.4)
47.6 (41.8, 53.4)

2495 (50.3)
1770 (35.7)
223 (4.5)
192 (3.9)
284 (5.7)

1773 (45.4)
1385 (35.5)
203 (5.2)
231 (5.9)
313 (8.0)
<0.001

57.6 (56.0, 59.2)
51.4 (48.6, 54.3)

3762 (75.8)
1202 (24.2)

2770 (70.9)
1135 (29.1)
<0.001

60.9 (56.6, 65.2)
58.6 (55.7, 61.5)
55.3 (53.1, 57.8)
53.4 (50.8, 56.1)

508 (10.1)
1144 (22.7)
2003 (39.6)
1379 (27.5)

330 (8.3)
813 (20.4)
1615 (40.7)
1207 (30.6)
<0.001

53.2 (51.3, 55.2)
59.1 (57.2, 61.1)

2529 (50.9)
2435 (49.1)

2221 (56.9)
1684 (43.1)
<0.001

58.6 (57.0, 60.1)
47.9 (44.8, 50.9)
58.4 (56.8, 60.0)

3930 (79.2)
1034 (20.8)
3734 (75.2)

2780 (71.2)
1125 (28.8)
2661 (68.1)

<0.001

Footnotes: The unadjusted prevalence of the 1-year surveillance colonoscopy (95% CI) and
the proportion of those that did and did not adhere to across the study period.
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Table 6.2. Adjusted prevalence ratios (95% CI) stratified by diagnosis year and age group
for adherence to the one-year surveillance colonoscopy.
< 65 Population
Race by sex
White male
White female
Black male
Black female
Rurality
Urban
Rural
Insurance
Commercial/HMO
Medicaid
Self-Pay
Other
Stage
Local
Regional
Primary Site
Large Intestine
Rectum
Race by sex

Rurality
Insurance

Stage
Primary Site

White male
White female
Black male
Black female
Urban
Rural
Commercial/HMO
Medicare
Medicaid
Self-Pay
Other
Local
Regional
Large Intestine
Rectum

2001 – 2007

2008 – 2013

1.00
1.04 (0.98, 1.12)
0.87 (0.78, 0.97) *
0.82 (0.73, 0.92) ***
1.00
0.87 (0.80, 0.94) ***
1.00
0.86 (0.74, 1.00)
0.71 (0.60, 0.85) ***
0.82 (0.72, 0.93) **
1.00
1.15 (1.08, 1.22) ***
1.00
0.83 (0.77, 0.90) ***

1.00
1.06 (0.98, 1.15)
0.86 (0.76, 0.98) *
0.98 (0.88, 1.10)
1.00
0.91 (0.84, 0.99) *
1.00
0.98 (0.87, 1.10)
0.85 (0.74, 0.98) *
0.87 (0.77, 0.98) *
1.00
1.10 (1.03, 1.18) **
1.00
0.78 (0.71, 0.85) ***

1.00
0.97 (0.90, 1.05)
0.73 (0.62, 0.87) ***
0.91 (0.81, 1.04)
1.00
0.89 (0.82, 0.97) **
1.00
1.10 (0.97, 1.26)
0.41 (0.12, 1.42)
0.91 (0.51, 1.62)
0.63 (0.35, 1.13)
1.00
1.08 (1.00, 1.16) *
1.00
0.88 (0.79, 0.97) *

1.00
1.01 (0.91, 1.13)
1.01 (0.86, 1.18)
1.02 (0.88, 1.19)
1.00
0.93 (0.83, 1.04)
1.00
1.15 (1.00, 1.32) *
0.96 (0.61, 1.51)
0.65 (0.28, 1.49)
0.49 (0.24, 1.01)
1.00
1.03 (0.94, 1.13)
1.00
0.83 (0.72, 0.95) **

Footnotes: * p < 0.05, ** p < 0.01, § p < 0.001
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Figure 6.1. Formation of the study population of adults diagnosed with CRC.

Legend

Figure 6.2. Age-adjusted prevalence of one-year surveillance colonoscopy in South
Carolina for male and female CRC survivors from 2002 – 2013.
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CHAPTER 7
SUMMARY
This dissertation provides a wide view of CRC, from screening access to
surveillance uptake. This is the first study to examine the CAs colonoscopy facilities for
an entire state, specifically using a method that modeled the realized demand. We also
used a unique approach to learn how the obesogenic environment affects colorectal
polyps, through different pathways. Finally, we provided the one-year surveillance
colonoscopy prevalence over time for the population of CRC survivors in SC and
identified racial disparities.
Chapter 4 illustrated how the colonoscopy centers in SC provided services for
patients across the entire state. Overall, the CA method was able to examine the realized
accessibility or utilization of patients receiving a screening colonoscopy in SC. The
catchment areas of these facilities span 88% of the ZIP codes in SC, leaving only a small
fraction outside of CAs, which were mainly along the state borders. Fifty-three percent of
the ZIP codes fell into 2-3 different CAs, which were typically located near the most
populated areas in SC. Diving further into each CA could elucidate accessibility to
facilities beyond geography. While most of the ZIP codes were included in at least one
CA, the patients in this study only represented individuals seeking a screening
colonoscopy and do not account for diagnostic or surveillance colonoscopies. Future
methods should account for the unscreened population as well as other colonoscopy
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procedures in order to expand these results to estimating the true available screening
capacity of colonoscopy providers.
The obesogenic environment measures the obesity-promoting aspects of a
neighborhood or community. While there have been mixed findings between the
obesogenic environment and CRC, work needs to be done to understand the relationship
with the precursor to CRC, or polyps. Polyps that continue to grow without being
removed can progress to cancer. In Chapter 5, we found that full-service restaurants had a
direct effect on having high-risk polyps. Our sensitivity analysis showed that when
accounting for unmeasured confounding, the positive aspects of the food environment
had the potential to reduce the risk of having a polyp. Research has shown that living in
an unhealthy environment does not always imply that one would have an equivalent
lifestyle. Even if one lives in an unhealthy environment, making good health decisions
within those communities can offset the overall effect of the environment. Our sensitivity
analysis also showed that obesity does mediate the effect of the obesogenic environment
on having a polyp and increased the risk of colorectal polyps. Future studies should
investigate what aspect of the obesogenic environment not through obesity has an effect
on colorectal polyps (e.g. water and air quality).
In Chapter 6, we explored whether increased access to health reduced racial
disparities in surveillance colonoscopy over time. Surveillance colonoscopies are
beneficial to survivors to prevent recurrence of CRC and prolong survival. The
prevalence of receiving a surveillance colonoscopy in SC decreased slightly over time
from 57% to 54% overall, from 58% to 56% for White men, 49% to 53% for Black men,
60% to 53% for White women, and 51% to 53% for Black women from 2002 to 2013.
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For adults younger than 65 years, there was a disparity in receiving a surveillance
colonoscopy where Black survivors were 14% less likely to receive the colonoscopy
compared to White survivors during both time periods. For Medicare-eligible adults at
least 65 years in age, the disparity was eliminated in the later study period. Having more
access to health insurance played a role in reducing the disparity in receiving timely care
to prevent cancer recurrence. Future studies could investigate how the disparities change
as the health care market continues to evolve, particularly for those that were formerly
uninsured.
Colorectal cancer is primarily preventable through a healthy lifestyle, which
includes regular screening colonoscopies and surveillance colonoscopies for recurrence
prevention. For SC, most of the age-eligible adults for CRC screening have access to
available resources. In addition to having available colonoscopy facilities, having access
to healthy outlets is beneficial to adults in reducing the risk of colorectal polyps. Taking
these steps have shown to prevent CRC. However, once CRC is discovered, early if
screened regularly, survivors can prolong their survival by receiving regular surveillance
colonoscopies. Future qualitative studies can explore what empowers individuals to
engage in healthy decision-making (like health screenings) in order to help tailor
community messages that would be effective in preventing chronic diseases like CRC.
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APPENDIX A
CODES TO IDENTIFY COLONOSCOPY
Table A.1. CPT, HCPCS, and ICD-9 codes to identify colonoscopy in outpatient dataset
Code
G0105
G0121
44388
44389
44390
44391
44392
44393
44394
44397
45355
45378
45379
45380
45381
45382
45383
45384
45385
45386
45387
45391
45392
45.21
45.22
45.23
45.25
45.41
45.42
45.43
48.24
48.36

Description
Colorectal cancer screening; colonoscopy on individual at high risk
Colorectal cancer screening; colonoscopy on individual not meeting the criteria
for high risk
Colonoscopy through stoma
Colonoscopy through stoma with biopsy
Colonoscopy through stoma with foreign body removal
Colonoscopy through stoma with control of bleeding
Colonoscopy through stoma with hot biopsy
Colonoscopy through stoma with ablation of tumor(s), polyp(s) or other lesion(s)
not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique
Colonoscopy through stoma with snare
Colonoscopy through stoma with transendoscopic stent placement
Transabdominal colonoscopy via colotomy
Colonoscopy
Colonoscopy with foreign body removal
Colonoscopy with biopsy
Colonoscopy with submucosal injection
Colonoscopy with control of bleeding
Colonoscopy with ablation of tumor(s), polyp(s) or other lesion(s) not amenable
to removal by hot biopsy, forceps, bipolar cautery or snare technique
Colonoscopy with hot biopsy
Colonoscopy with snare
Colonoscopy with dilation
Colonoscopy with transendoscopic stent placement
Colonoscopy with endoscopic ultrasound
Colonoscopy with endoscopic ultrasound with FNA
Transabdominal endoscopy of large intestine
Endoscopy of large intestine through artificial stoma
Colonoscopy
Endoscopic biopsy of large intestine
Excision of lesion or tissue of large intestine
Endoscopic polypectomy of large intestine
Endoscopic destruction of other lesion or tissue of large intestine
Endoscopic biopsy of rectum
Endoscopic polypectomy of rectum
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APPENDIX B
PREVALENCE ESTIMATES OVER TIME
Table B.1. Prevalence (%) of 1-year surveillance colonoscopy by race and sex over time

Year
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013

Overall
Population
57.0
58.9
53.8
57.5
55.2
55.7
53.8
55.5
53.8
58.2
55.4
54.2

Men
White
58.2
59.2
55.0
60.1
57.5
60.0
58.9
55.2
55.3
58.5
52.1
55.9

Black
49.2
44.9
51.7
47.9
43.7
44.1
46.5
59.8
45.2
47 .0
47.6
52.9
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Women
White
Black
60.4
51 .0
67.6
51.2
56.3
45.7
61.1
49.9
61.7
49.6
61.9
41.6
52.8
48.1
54.1
55.8
58.5
50.4
62.3
64.1
61.7
58.9
53.2
53.9

